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1.1 Mitogen activated protein kinases (MAPK) in general 
Cells communicate in multicellular organisms; by secreting and sensing signals, in 
order to adjust their behavior to the environment. Extracellular signals such as 
cytokines and growth factors bind to cell surface receptors and trigger the activation 
of multiple protein signal transduction cascades that mediate cellular responses 
such as proliferation, differentiation, apoptosis and motility. The Mitogen-activated 
protein kinase (MAPK) family is a group of homologous proteins forming several 
linear signal transduction pathways functioning in translating environmental cues 
into cellular behaviour Fig1. MAPKs exhibit their function in the form of sequential 
phophorylation events leading to two outcomes. The formation of functional 
signalling complexes in the nucleus to influence gene regulatory networks 
underlining cellular transformations induced by the environment. Alternatively, 
MAPKs could be retained in the cytoplasm and influence activity of cytoplasmic 

















MAPK are classified into three subfamilies according to the middle amino-acid 
residue of the conserved Thr-X-Tyr dual-phosphorylation motif; the extracellular 
signal regulated kinases (Erk1,2,3,4,5,6,7) with a Thr-Glu-Tyr, the c-Jun amino-
terminal kinases (Jnk1/2/3) have a Thr-Pro-Tyr motif and the P38 MAPK (α,β,γ, and 
Fig1: MAPK pathways. The 
MAPK family consist of the ERK, 
JNK and P38 subfamilies.  Most of 
the MAPK family members are 
functional within a MAPKKK-
MAPKK-MAPK signaling cascade 
that is stimulated by members of 
the small GTPase family such as 
RAS,RAC,CDC42 and RHO. 
Small GTPases are kept in an 
GTP bound active state by 
Guanine nucleotide exchange 
factors (GEFs) which relay the 
signal from membrane bound 
activated receptors. Activated 
MAPK could translocate to the 
nucleus and influence gene 
expression networks.  Liu et al. 




Δ) a Thr-Gly-Tyr. Phosphorylation of the Thr-X-Tyr motif activates the MAPK and 
occurs either by an upstream MAPK Kinase (MAPKK) or by 
autophosphorylation[2,3]. The MAPKK, (also called Mek) are in turn phosphorylated 
at Ser/Thr residues by upstream MAPKK Kinases (MAPKKK  or Mekk) which could 
be activated by small GTP-binding proteins of the Ras/Rho family which relay 
signals from receptor tyrosine kinases (Rtk), integrins or G-protein coupled 
receptors[4-6].  
 
MAPKs control the activity of numerous transcription factors and cytoplasmic 
proteins, including other kinases, by phosphorylation of Ser/Thr residues [7-9]. 
Transcription factor phosporylation occurs in the nucleus after translocation of 
MAPK as monomers [10]. MAPK could also form dimers and functional complexes 
with scaffold proteins to regulate signal transduction events in the cytoplasm. 
Scaffolding proteins are adaptor or anchoring proteins that bind multiple signalling 
proteins and create a functional complex at a particular subcellular location 
Fig2[11]. The cellular response is mediated by the duration of MAPK activity which 












Fig2: Spatio-temporal regulation of the MAPK phosphorelay system by 
Scaffold proteins. MAPK signaling cascades can be organized into functional 
complexes at a specific subcellular location by interaction with scaffolding proteins. 
Paxillin is a scaffold protein recruiting the RAF-MEK-ERK cascade to focal 
adhesions which are large, dynamic protein complexes through which the 
cytoskeleton of a cell connects to the extracellular matrix. Following c-met 
activation, by the hepatocyte growth factor (HGF), paxillin binds and recruits the 
MAPK cascade to focal adhesion where activated ERK phosphorylates paxillin at 
S83 creating a binding site for focal adhesion kinase (FAK) at the scaffold and 
subsequent activation of phosphatidylinositol 3-kinase (PI3K) and Rac. This results 





motif by MAPK kinases and phosphatases[12]. MAPK phophatases (MKPs) 
inactivate the pathway by direct dephosphorylation of both the tyrosine and 
threonine residues of the dual phosphorylation motif[12].  Protein Tyrosine 
Phosphatases (PTPs) switch off the receptor signal through inactivation of upstream 
pathway members including RTK[13]. Finally, protein serine/threonine 
phosphatases (PSPs) act downstream of MAPK by removing phosphates of 
substrates. Interestingly, PP2A is a MEKK1 phosphatase which is activated by P38 
during stress creating an inhibitory effect on Erk1/2 induced proliferation.  
 
The MAPK family is conserved among eukaryotes and most vertebrates contain at 
least 14 MAPKs, 7 MAPKKs, and 20 MAPKKKs. Because of the characteristic 
conformation of both the MAPK activation loop containing the (Tyr-X-Thr) motif and 
the kinase pocket of MAPKKs this interaction is highly specific yet allows for some 
redundancy especially between closely identical isoforms from the same subfamily 
such as Erk1 and Erk2 or P38α and P38β. The 14 mammalian MAPKs can 
therefore be divided into four conventional MAPK signalling cascades and atypical 
MAPKs which are possibly constitutively active.  
The first identified (canonical) cascade includes Erk1/2 which are specifically 
activated by Mek1/2 and initially discovered to be stimulated by growth factors (Egf, 
Pdgf, Igf and Fgf). The canonical MAPK pathway is stimulated after binding of Egf 
with its receptor. Ligand bound Egfr signals through adapter protein Grb2 and the 
Gef Sos to activate the small GTPase family member Ras. Ras transmits the signal 
to the MAPK cascade by recruiting Raf to the cell membrane for activation. Raf is a 
MAPKKK, the first kinase of the Erk1/2 cascade, which phosphorylates Mek1 and 
Mek2. Several other mitogen receptors, such as lpdgfr, Fgfr, Ngfr and Igfr, stimulate 
the pathway after ligand binding. 
P38α,β,γ,Δ constitute the second cascade and are activated by Mek3 and Mek6 but 
also Mek4 which creates a crosstalk with the third cascade including Jnk1/2/3 and 
Mek7. Both P38α,β,γ,Δ and Jnk1/2/3 pathways are initially discovered to be 
stimulated by stress signals such as X-ray/UV irradiation, heat/osmotic shock, and 
oxidative/nitrosative stress as well as by proinflammatory cytokines. The fourth 
cascade with Erk5 and Mek5 is also activated by cellular stressors, cytokines and 
growth factors which are transmitted through Mekk2 and Mekk3. Erk5, also referred 
to as big MAPK kinase 1(Bmk1), has a larger C-terminal region containing an auto-
inhibitory domain and nuclear localization signal[7,14-17]. Fig1. 
 
Since the first discovery in 1990, research involving gene expression and functional 
analysis for identified members of the MAPK family is ongoing.  Functional 
experiments with methods ranging from genetic engineering, pharmacological 
inhibition, siRNA or transgene expression are frequently used to outline specific and 
redundant functions of the various MAPK family members within certain contexts. 
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Some MAPK isoforms are widely expressed and functional in a great number of cell 
types ranging from embryonic to terminally differentiated lineages. In addition, 
MAPKs are discovered to be critically involved in severe disorders including cancer, 
Alzheimer, autoimmune/inflammatory diseases and also human genetic hereditary 
disorders [7,18-21]. How the existing closely related isoforms of a protein family,  
sharing sequence and functional domain similarities, take part in orchestrating 
cellular behaviours is in general a fundamental research topic with great scientific 
Fig3: The different MAPK cascades and their function in development. The identified 
MAPK pathways: ERK1/2, JNK1/2/3, p38α/β/γ/δ, ERK5, ERK3/4 and ERK7. The function, 
obtained by gene targeting or silencing studies are described for each MAPK. The lethality-
index indicates if gene-disruption in mice resulted in a lethal developmental phenotype and 
at what day of development (†=lethal, No=not lethal, ND=not determined). erk3−/− mice 
neonates die within minutes after birth from acute respiratory failure. Recently (Rousseau et 
al. 2010) Erk4 is shown to be dispensable for mouse embryonic development. Figure from 




value for molecular cell biology.  Distinction of MAPK isoform signalling could also 
be beneficial in medical science related to MAPK associated diseases. Strategic 
invention of effective pharmaceuticals causing limited side effects requires facts of 
MAPK isoform specific signalling within relevant cellular and micro-environmental 
context.   
 
1.2 MAPK in embryonic development 
 
1.2.1 Lessons from In vivo and In vitro knock-out studies in mice.  
In vivo functional distinction of MAPK family members has been achieved in 
particular with the gene-targeting technology in mice. Defects resulting from 
homologous recombination to disrupt the endogenous gene of interest are reported 
for most MAPK isoforms except Erk7 and Erk8 Fig3.  Proteins indispensible for 
embryonic development could be functional in specific events such as patterning to 
establish the body plan or control pluripotent cell differentiation into lineages of cells 
and tissues. Functional studies could provide insight into the underlying 
mechanisms of human developmental genetic disorders.   
 
Several studies have demonstrated Erk2, Erk5 and P38α to be essential for early 
vertebrate development and each fulfil a role that could not be compensated by 
other MAPK family members. Jnk1 and Jnk2 are fully functional redundant in 
regulation of early brain development.  Jnk1-/- Jnk2-/-  double knock-out mice die at 
E.11 due to defects in neural tube closure and deregulated neural apoptosis while 
embryos from single knock-outs showed no severe morphological 
abnormalities[22,23]. In contrast, a genetic study with embryonic stem cells (ESC) 
suggested that only the Jnk1 isoform was essential for neural differentiation induced 
by retinoic acid [24]. The expression of wnt-4 and wnt-6, inhibitors of ES cell 
neurogenesis, was found significantly elevated in JNK1(-/-) cultures relative to wild-
type, JNK2(-/-), and JNK3(-/-) cultures. In addition, adult mice Jnk1 or Jnk2 single 
knock-out display defects of activated T lymphocyte differentiation into T-helper 
cells [25,26].  
 
Erk2 plays a unique role during gastrulation, the differentiation of endoderm, 
mesoderm and ectoderm cell layers of embryonic blastocysts [27-29].  Gastrulation, 
the differentiation of endoderm, mesoderm and ectoderm cell layers of the 
blastocyst, is regulated by morphogens such as Fgf, Bmp, Wnt and Nodal which 
collectively orchestrate patterning and cell specification of the vertebrate and the 
invertebrate embryo. The Erk1/2 cascade functions downstream of Fgf and is 
involved in specification of the mesoderm, neural induction, anterior-posterior 
patterning and FGF formation during gastrulation[30]. Pluripotent mice ESC lacking 
either FGF4/ERK2 autocrine signalling resist mesodermal and neuronal induction 
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[31]. The Fgf-Erk pathway is an autoinductive stimulus for naive ES cells to exit the 
self-renewal programme and differentiate towards a state that is responsive to 
inductive cues for germ layer segregation[31,34,35]. The mesoderm defective 
phenotype was  demonstrated in vivo with Erk2-deficient mice as well which also fail 
to induce the mesoderm cell fate[32]. Erk2 deficient embryos showed also 
increased apoptosis but proliferation was unaffected. In many somatic cell types, 
the Erk1/2 cascade is stimulated by mitogens and plays a prominent role in inducing 
proliferation. The mitogen stimulated ERK1/2 promotes proliferation by translocation 
to the nucleus for direct phosphorylation of transcription factors ets1, c-myc, c-jun, 
fos and indirect phosphorylation of CREB through p90RSK. Hyperactivation of the 
Erk1/2 cascade, as a result of upstream EGFR, RAS and RAF oncogene activity, is 
associated with uncontrolled proliferation of tumours. However undifferentiated mice 
ESC, sharing the same proliferative characteristics as transformed cells,  do not 
require the Erk pathway for proliferation and expression of self-renewal markers 
Oct4, Nanog and Rex[33]. In fact, ESC and transformed cells can be propagated 
clonally, multiply in absence of serum and are not subject to contact inhibition or 
anchorage dependence. However attenuation of ERK signalling, by 
pharmacological inhibition of MEK activity or by ectopic expression of ERK 
phoshatases, facilitates self-renewal by reducing differentiation specifically in ESC.  
Erk2 Knock-out in another in vivo background (C57BL/6 mice) leads also to 
embryonic lethality early in mouse development but after the implantation stage and 
reveals that Erk2 is essential for the formation of the placenta. Erk2-/- mice failed to 
form extra-embryonic ectoderm and the ectoplacental cone which differentiate from 
trophoblasts[36]. Erk2 is therefore involved in the first embryonic differentiation 
event where the blastocyst segregates into two cell lineages the trophoblast, which 
will specifically develop into extra-embryonic tissue forming the placenta, and the 
inner cell mass (ICM) which will predominantly give rise to the fetus.  
 
Several studies using different background mice and knock-out approaches have 
shown that P38α knock-out is embryonic lethal within the first 12 days. Defects 
observed in P38α -/- mice include aberrant placental angiogenesis, increased 
apoptosis and massive reduction of the myocardium [27,37-39].  At the cellular 
level, P38α is abundantly present in ESC however knock-out did not affect 
endothelial, smooth muscle and neuronal cell differentiation. P38α-/- ESC have 
significantly increased cell adhesion to several extracelluar matrix proteins, 
correlating with elevated phosphorylation of focal adhesion kinase and paxillin. 
P38alpha -/- ESC also showed increased cell viability, correlating with increased 
expression of survivin and activation of AKT (protein kinase B)[40].   
 
The Mek5/Erk5(Bmk1) cascade plays a role in embryonic development after the 
gastrulation stage. Erk5 deficient mice displays aberrant extra-embryonic (placental) 
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and embryonic blood vessel organization and maturation. Erk5 plays a role in 
controlling angiogenesis most likely by regulating endothelial cell survival. 
Histological and In vitro examination showed that endothelial cells lost their integrity, 
became round and eventually apoptotic. Also Cardiac development was largely 
retarded in Erk5-/- mice, and the heart failed to undergo normal looping [41].   
 
1.2.2 MAPK in zebrafish development.  
The disadvantage of the gene knock-out technology in mice is that it is time 
consuming and costly. The zebrafish is a much better alternative to screen for 
embryonic important genes. Synthetic antisense oligonucleotides known as 
morpholinos can be injected easily in batches of first stage zebrafish embryos for 
targeted knock-down of endogenous genes. A pair of adult zebrafish could lay 100 
to 200 embryos according to a 10 hour light cyclus and batches of embryos of a 
particular stage can be obtained for experimentation. The ex-utero development and 
transparency of the embryo makes it possible to record phenotypes in wild type or 
transgenic fluorescent zebrafish lines. With the current available zebrafish tools 
molecular mechanisms could be identified and linked to cellular processes and 
morphological observations.   
All 14 zebrafish MAPK genes are evolutionary conserved in zebrafish and analysis 
of phylogeny, based on zebrafish, mice, rat, xenopus, and human amino acid 
sequence similarity, shows that the different vertebrate MAPK cluster with their 
corresponding orthologs[28]. Most zebrafish MAPK are recently cloned and 
characterized by our laboratory using semi-quantitative RT-PCR expression 
analysis of different developmental stages and whole mount in situ hybridization for 
expression localization[42]. Further efforts for functional elucidation in zebrafish 
embryology have been performed for ERK1, ERK2, P38α and JNK1. The Current 
thesis described additional two MAPK members of the P38 subfamily: the P38β and 
P38δ isoforms.  
FGF activation of the ERK1/2 cascade is also in the zebrafish embryo a critical 
molecular event during gastrulation. Zebrafish gastrulation occurs during epiboly a 
morphogenetic movement of the blastoderm over the interface of the yolk until fully 
covered. When the cells reach the equatorial region of the embryo the three cellular 
germ layers are formed depending on positional cues and distinct cell migratory 
properties provided by interplay of Bmp, Nodal, Wnt and Fgf morphogen gradients 
[43,44]. The Fgf protein family contains 23 members of which Fgf8, Fgf3, Fgf17b 
and Fgf24 are expressed at the margin of the migrating blastoderm during 
epiboly[45]. Erk1 and Erk2 are expressed throughout the blastoderm however 
activity is detected with Erk1/2 immuno-staining at the margin[46]. Morpholino 
knock-down of both MAPKs identifies Erk2 as a critical mediator of epiboly cell 
movements and differentiation of mesodermal cell fate[46]. Saturated Erk2 knock-
18 
 
down prevents a large pool of embryos from initiating epiboly and the remaining 
from convergent extension movements that occur at 50% epiboly during the actual 
segregation of the germ layers. Transcriptional profiling of Erk2 morphants revealed 
downregulated mesoderm specific T-box transcription factors which are also known 
to be regulated by Fgf8[54]. Furthermore the Ap1 and Ets2 transcription factors are 
known Erk2 direct substrates and functional in Fgf induced mesoderm formation in 
xenopus[55,56]. Erk1 knock-down resulted only in a mild effect on epiboly 
progression without effect on mesoderm markers expression. P38α and its direct 
substrate Mapkapk2 are implicated in zebrafish epiboly as well [57,58]. However the 
molecular mechanism upstream and the downstream signaling during zebrafish 
gastrulation remain still unclear. Perhaps the Fgf pathway does also influence the 
P38α MAPK signaling. In somatic cells P38α can be activated by growth factors via 
the similar Grb2-Sos-Ras pathway which lead to the activation of the Raf-Mek1/2-
Erk1/2 pathway from activated receptor tyrosine kinases. Growth factor stimulated 
Ras can also activate Cdc42 and Rac/Posh which will lead to activation of the Mixed 
Lineage Kinase Mlk2/3 which are MEKK upstream of P38 and also Jnk MAPKs[59]. 
The non-canonical Wnt pathway, also a major regulator of cell migration during 
gastrulation, could also recruit Rac to activate the Jnk module in Xenopus and 
mammalian cells [60].  Alterations in Rac or Jnk activity did disrupt Xenopus 
gastrulation and polarized cell movements. In zebrafish knock-down of Jnk1 did not 
result in severe defects in migration (unpublished data). Since functional 
redundancy of Jnk1 and Jnk2 was demonstrated previously in mice, the function in 
zebrafish epiboly might still be continued to be performed by Jnk2 despite reduced 
levels of Jnk1 in these embryos. Like in mice, a double Jnk1 and Jnk2 morpholino 
knock-down in zebrafish would reveal its possible function if this is the case. 
However this thesis focuses on the role of P38 and Erk2 MAPK in zebrafish early 
development.  
Other early embryonic activities regulated by Fgf morphogens, and possibly the 
downstream Erk cascade, during gatrulation are dorso-ventral patterning, neural 
induction,  endoderm formation and left-right assymmetry [30,47-49]. Over 
activation of Fgf8/Fgfr1/Ras/Mek signaling pathway leads to regional expansion of 
Bmp antagonists Chordin, Noggin and Follistatin expression which mark the dorsal 
side. Consequently the expression of Bmp ventral markers Bmp2b and Bmp4 is 
significantly reduced[49]. Dorsalized embryos appear extremely elongated which 
was the case after over activating a member of the Fgf8/Fgfr1/Ras/Raf/Mek 
cascade [47,50-52].  Neural induction is the process whereby naive ectodermal cells 
are instructed to adopt a neural fate. The ectoderm gives rise to both the neural 
tissue and the epidermis. Impeding FGF signaling results in a shift of posterior 
ectodermal markers from neural to epidermal. Dominant negative RAS blocks 
induction of posterior neural markers [53]. Conversely, over expression of Fgf3 
expands posterior neural tissue. Anterior neural tissue, along with posterior 
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neuronal fate, fails to develop when inhibiting both FGF and Nodal signaling during 
zebrafish gastrulation. Specification of the neural plate requires repression of BMP 
signaling in the dorsal ectoderm. The FGF-MEK-ERK pathway induces expression 
of BMP antagonists and is able to block BMP binding to the receptor. However, an 
alternative pathway is also suggested since FGF signaling was able to repress BMP 
expression in absence of protein synthesis. The interaction of FGF/ERK pathway 
with BMP and Nodal signaling is also crucial for endoderm formation. While the 
ectoderm germ layer arises from the animal pole region of the embryo, the 
mesoderm and endoderm progenitors are located at the margin at the expression 
region of Nodal and Fgf. The endoderm progenitors arise from the first four rows of 
marginal cells, while the mesoderm develops from the entire marginal region. 
Endoderm specification is repressed in regions with both FGF/Erk and Bmp 
expression. Although FGF expression ovelaps the most vegetal marginal cells 
which develop into endoderm, BMP morphogens are absent in this region. Left-right 
assymmetry of the brain, heart and gut is regulated in the zebrafish by a ciliated 
epithelium inside a fluid-filled organ called Kupffer’s vesicle which arise from dorsal 
forerunner cells during gastrulation. Multiple Kupffer’s vesicles migrate ahead from 
the migrating margin establishing a directional fluid flow resulting in asymmetrical 
gene expression that leads to asymmetrical organogenesis. The fibroblast growth 
factor (FGF) signalling regulates cilia length and function in diverse epithelia during 
zebrafish and Xenopus development. Morpholino knockdown of FGF receptor 1 
(Fgfr1) in zebrafish cell-autonomously reduces cilia length in Kupffer’s vesicle and 
perturbs directional fluid flow required for left–right patterning of the embryo. 
Expression of a dominant-negative FGF receptor (DN-Fgfr1), treatment with 
SU5402 (a pharmacological inhibitor of FGF signalling) or genetic and morpholino 
reduction of redundant FGF ligands Fgf8 and Fgf24 reproduces this cilia length 
phenotype. 
 
1.3 Structural comparison of P38 and ERK MAPK  
The effect of MAPK signalling into different possible cellular outcomes depends on 
presence of kinases and phosphatases that regulate the on and off switching of the 
MAPK [61,62]. The mechanism of MAPK activation is much more understood since 
the crystal structures of both the low-activity, (unphosphorylated) and high-activity 
(phosphorylated) forms are resolved with X-ray crystallography Fig4. Especially 
research focused on Erk2 structural changes following phosphorylation provided 
insight into a common mechanism controlling activation and substrate specificity for 
protein kinases in general [61-65]. Folded protein kinases appear in two spherical 
lobes; the N-lobe and the C-lobe with the catalytic site in between Fig4a. The N- 
and C-lobes rotate apart to release substrates or together to align the catalytic site 
residues located at the interface of the two lobes [66]. The proper juxtaposition of 
active site residues on both lobes enables phosphoryltransfer from ATP to  
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Fig4: Predicted three-dimensional structure of zebrafish Erk2. Homology models are 
obtained of unphosphorylated and phosphorylated zERK2 using 1ERKA and 2ERKA 
respectively (PDB). A Surface and ribbon figure showing protein features common to other 
protein kinases including cyclin-dependent kinase-2 (CDK2), cAMP-dependent protein 
kinase (PKA), phosphorylase kinase (PHK) and the Tyr kinase domain of the insulin 
receptor (IRK). Except the tyrosine residue of the dual phosphorylation site which is unique 
for MAPKs. B MAPK have two allosteric docking sites. The CD-site (ball and stick residues) 
is located on the C-terminal extension (red) and the groove for DEF domain docking is 
located between α-helix G, the MAPK insert (yellow) and activation loop. The P+1 site (pink) 
is also involved in substrate kinase interaction. Catalytic residues are located in the glycine 
rich loop (cyan), catalytic loop (blue) and α-helix C. C Superposition of unphosphorylated 
and phosphorylated zERK2. Phosphorylation of Thr-183 and Tyr-185 results in reorientation 
of the activation loop, glycine rich loop and MAPK insertion consequently leading to MAPK 



















substrate. In the C-lobe the activation site of the kinase and allosteric docking sites 
for interacting proteins are situated. The C-terminal region folds back spans both 
domains and terminates in close approximation of the N-terminus Fig4b (red). This 
C-terminal extension is longer in MAPK kinases and is important for stable protein 
folding and recognition of interacting proteins. The N-lobe of MAPKs consist of a 
several loops, a β-sheat and 2 helices α-helix C and α-helix L16. The latter being 
part of the C-terminal extension. Some residues of the catalytic site for ATP binding 
are located in α-Helix C. The C-lobe is mainly composed of α-helices but contains 
also several short β-strands and loops with catalytic residues that are clustered in 
the catalytic loop Fig4b (blue). The catalytic loop is allosterically controlled by Loop 
12 (activation loop) at the surface of the C-lobe.  
 
Loop 12 contains the dual-phosphorylation site Thr-183 and Tyr-185 (TEY motif rat 
Erk2 numbering) for kinase activation. Upon phosphorylation the activation loop 
changes conformation making the MAPK kinetically active and accessible for 
substrates Fig4c. Thr-183 and Tyr-185 induce conformational changes differentially 
and contribute therefore separately to the activation of the protein. Tyr-185 is unique 
for MAPKs which is part of a highly conserved P+1 sequence (YVATRWYR) Fig4b 
(pink). After phosphorylation the P+1 sequence forms an pocket for interaction with 
the phosphoacceptor site on substrates. MAPK phosphorylate substrates at Serine 
and Threonine residues next to a Proline residue (P+1). This interaction is inhibited 
by the side chain of unphosphorylated Tyr-185 which occupies the pocket. 
Phosphorylation of the Thr-X-Tyr motif induces rearrangements of hydrogen bonds 
and ionic contacts with other residues and cause the tyrosine side chain to face the 
surface of the molecule. This process opens the P+1 pocket for Proline and places 
the Ser/Thr residue of the substrate to the correct position for phospho-transfer[67]. 
Phospho-Thr-183 rearranges active site residues by forming direct ionic contacts 
with arginine residues in α-helix C (Arg-68), in the catalytic loop (Arg-146) and in the 
activation loop (Arg-170). These interactions create two extended networks of 
interacting amino acids that connect the activation loop with α-helix C and the C-
terminal extension while changing the orientation of the N-terminal and C-terminal 
domains. Phosphorylated Tyr-185 increases the accessibility for substrates binding.  
 
In addition the C-domain contains two allosteric docking sites that confer specificity 
for substrates referred to as the CD-site and a DEF/ED domain docking site. The 
CD-site is a docking site located on the C-terminal extension accessible for 
substrates containing a DEJL motif with consensus sequence Arg/Lys2-Xaa2–6-
Faa-Xaa-Faa (where Faa are the hydrophobic residues Leu, Ile or Val). In the CD 
domain of MAPKs, two or three acidic amino acids (D330, D327 zERK2) forms an 
acidic cluster which is crucial for docking to a cluster of basic amino acids 






DEF/ED site (Phe-X-Phe) and dock in a hydrophobic groove Fig4b (green) 
between the loop the activation loop, α-helix G and the MAPK insertion Fig4b 
(yellow)[61,68-70] [71].  
 
The existing structural differences between P38 and Erk influence the affinity for 
substrate binding and underlie therefore the specification of their biological function.  
The first obvious structural differences is the change in conformation of the 
activation loop which is 6 residues shorter in P38 than Erk2 causing a  replacement 
of the Thr and Tyr phosphorylation sites. This could lead to differences in the 
binding affinity of activators (MEKs) and substrates. The length of the activation loop 
also plays an important role in controlling autophosphorylation. Other structural 
differences are observed when looking at the α-Helix C in the N-terminal domain 
which is rotated in P38 in respect to its position in Erk2. In addition the interactions 
between the C-terminal extension (α-Helix L16) and the other part of the N-terminal 
domain are weaker. These differences result in a relatively open ATP binding site in 
P38.  
 
1.4 Scope of the thesis  
The documented 30 years of research focus on the MAPK protein family is a rich 
source of information on molecular roles linked to cellular behaviour. Activation of 
MAPK cascades leads to precise cellular responses depending on intrinsic cell-type 
specific factors and the nature and abundance of the extracellular signal(s) in the 
cellular microenvironment. We are interested in the molecular mechanisms of 
MAPK signalling that facilitate proper development of the zebrafish embryo. The first 
stages of embryonic development involves divers, often in parallel occurring, cellular 
behaviours that contribute to the formation of the body plan such as proliferation, 
cell fate decisions, adjustment of cell motility and adhesiveness. Most MAPK family 
members are expressed at an early stage of development and might be part of the 
underlying mechanisms. Using four different approaches (Chapter 2-5) we aimed, 
with the present study, to contribute to the elucidation of Erk1/2 and P38 MAPK 
molecular mechanisms during zebrafish early development.  
 
Description of the Erk/MAPK three-dimensional protein structure, identification of 
pathway components and biochemical studies describing signal amplitude, duration 
and localization in divers biological systems where of great value for explaining how 
a single MAPK cascade could be involved in different cellular behaviours. Models of 
distinguished MAPK transient, oscillatory, bistable and ultrasensitive signalling shed 
light into the multitasking capacity of Erk2. Further enrichment of this knowledge will 
add to our understanding of the imbalanced Erk2 signalling observed in 
tumorigenesis and provide a fundament for treatment design and prediction. To 
adjust Erk2 kinetic activity amino-acid substitutions were introduced and the effect 
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on downstream signalling and gene transcription were assayed based on well 
established molecular mechanisms. We constructed constitutive active zebrafish 
Erk2 mutants that will be used for identification of new signalling events in the 
context of embryology (Chapter 2). In future genomic incorporation of the mutants 
and engineering of zebrafish transgenic lines with tissue specific stable expression 
would be valuable for modelling Erk2 associated diseases.         
 
Analysis of P38/MAPK isoform specific expression in organ tissues and during 
different time points of the developing zebrafish embryo is a first step for detailed 
functional elucidation of this cascade. With the second experimental chapter we 
completed expression analysis of all P38 isoforms by expression analysis of the 
P38β and P38δ isoforms. Like most MAPK, expression of both transcripts was 
detectable within the first 24 hours of zebrafish development and at 1dpf, when the 
body plan was completed, expression was most saturated in the brain 
compartments.  The P38β transcript was maternally present and stably expressed 
during the first stages of development. P38δ expression started after zygotic 
transcription and varied in different stages (Chapter 3).  
 
We performed also a comparative study between P38α and Erk2 MAPK since both 
are essential in a similar process during development. Morpholino knock-down of 
either P38α or Erk2 disrupts epiboly an embryonic process involving germ layer 
segregation which occurs in zebrafish from 5 to 10hpf. Transcriptome analysis of 
P38α and Erk2 morphants at high/oblong stage, approximately an hour before 
initiation of epiboly, revealed large, partly overlapping pools of genes functional in 
different aspects of early development such as morphogen pathway, cell adhesion 
and migration. Interestingly, some genes functional in later established tissues of 
the immune system or nervous system were affected by P38α or Erk2 knock-down. 
In addition, inhibition of endogenous P38α expression affects a significant pool of 
ribosomal proteins. We hypothesize that this molecular link can be attributed to the 
role of P38α in maintaining cellular integrity during stress (Chapter 4). 
 
Mammalian P38α deficiency resulted in aberrant placental angiogenesis and many 
in vitro studies in endothelial cells mapped P38α downstream of Vegf a key growth 
factor for endothelial proliferation and vascular remodelling. We questioned whether 
this role was conserved in zebrafish by unsaturated morpholino knock-down in 
Tg:fli+eGFP zebrafish. We addressed the role of P38α in zebrafish angiogenesis 
and found that P38α depletion had no effect on vasculogenesis but disrupted 
outgrowth of intersegmental vessels (ISV) from the dorsal aorta in the trunk of the 
zebrafish embryos. Angiogenesis of intersegmental vessels was completely blocked 
after treatment with the P38 inhibitor Birb796.  With transcriptional analysis we 





 1.  Kyriakis JM, Avruch J: Mammalian MAPK signal transduction pathways activated by 
stress and inflammation: a 10-year update. Physiol Rev 2012, 92:689-737. 
 2.  Plotnikov A, Zehorai E, Procaccia S, Seger R: The MAPK cascades: Signaling 
components, nuclear roles and mechanisms of nuclear translocation. Biochimica et 
Biophysica Acta (BBA) - Molecular Cell Research 2011, 1813:1619-1633. 
 3.  Kim L, Del RL, Butcher BA, Mogensen TH, Paludan SR, Flavell RA, Denkers EY: 
p38 MAPK autophosphorylation drives macrophage IL-12 production during 
intracellular infection. J Immunol 2005, 174:4178-4184. 
 4.  Chen Q, Kinch MS, Lin TH, Burridge K, Juliano RL: Integrin-mediated cell adhesion 
activates mitogen-activated protein kinases. J Biol Chem 1994, 269:26602-26605. 
 5.  Katz M, Amit I, Yarden Y: Regulation of MAPKs by growth factors and receptor 
tyrosine kinases. Biochim Biophys Acta 2007, 1773:1161-1176. 
 6.  Naor Z, Benard O, Seger R: Activation of MAPK cascades by G-protein-coupled 
receptors: the case of gonadotropin-releasing hormone receptor. Trends Endocrinol 
Metab 2000, 11:91-99. 
 7.  Bogoyevitch MA, Kobe B: Uses for JNK: the many and varied substrates of the c-
Jun N-terminal kinases. Microbiol Mol Biol Rev 2006, 70:1061-1095. 
 8.  Trempolec N, Dave-Coll N, Nebreda AR: SnapShot: p38 MAPK signaling. Cell 2013, 
152:656. 
 9.  Yoon S, Seger R: The extracellular signal-regulated kinase: Multiple substrates 
regulate diverse cellular functions. Growth Factors 2006, 24:21-44. 
 10.  Casar B, Pinto A, Crespo P: Essential role of ERK dimers in the activation of 
cytoplasmic but not nuclear substrates by ERK-scaffold complexes. Mol Cell 2008, 
31:708-721. 
 11.  Pullikuth AK, Catling AD: Scaffold mediated regulation of MAPK signaling and 
cytoskeletal dynamics: a perspective. Cell Signal 2007, 19:1621-1632. 
 12.  Caunt CJ, Keyse SM: Dual-specificity MAP kinase phosphatases (MKPs): shaping 
the outcome of MAP kinase signalling. FEBS J 2013, 280:489-504. 
 13.  Barr AJ, Knapp S: MAPK-specific tyrosine phosphatases: new targets for drug 
discovery? Trends Pharmacol Sci 2006, 27:525-530. 
 14.  Abe MK, Kuo WL, Hershenson MB, Rosner MR: Extracellular signal-regulated 
kinase 7 (ERK7), a novel ERK with a C-terminal domain that regulates its activity, its 
cellular localization, and cell growth. Mol Cell Biol 1999, 19:1301-1312. 
25 
 
 15.  Cuadrado A, Nebreda AR: Mechanisms and functions of p38 MAPK signalling. 
Biochem J 2010, 429:403-417. 
 16.  Zebisch A, Czernilofsky AP, Keri G, Smigelskaite J, Sill H, Troppmair J: Signaling 
through RAS-RAF-MEK-ERK: from basics to bedside. Curr Med Chem 2007, 
14:601-623. 
 17.  Nithianandarajah-Jones GN, Wilm B, Goldring CE, Muller J, Cross MJ: ERK5: 
structure, regulation and function. Cell Signal 2012, 24:2187-2196. 
 18.  Kyriakis JM, Avruch J: Mammalian MAPK signal transduction pathways activated by 
stress and inflammation: a 10-year update. Physiol Rev 2012, 92:689-737. 
 19.  Roberts PJ, Der CJ: Targeting the Raf-MEK-ERK mitogen-activated protein kinase 
cascade for the treatment of cancer. Oncogene 2007, 26:3291-3310. 
 20.  Dhillon AS, Hagan S, Rath O, Kolch W: MAP kinase signalling pathways in cancer. 
Oncogene 0 AD, 26:3279-3290. 
 21.  Rodriguez-Viciana P, Tetsu O, Tidyman WE, Estep AL, Conger BA, Cruz MS, 
McCormick F, Rauen KA: Germline mutations in genes within the MAPK pathway 
cause cardio-facio-cutaneous syndrome. Science 2006, 311:1287-1290. 
 22.  Kuan CY, Yang DD, Samanta Roy DR, Davis RJ, Rakic P, Flavell RA: The Jnk1 and 
Jnk2 protein kinases are required for regional specific apoptosis during early brain 
development. Neuron 1999, 22:667-676. 
 23.  Sabapathy K, Jochum W, Hochedlinger K, Chang L, Karin M, Wagner EF: Defective 
neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and 
JNK2. Mech Dev 1999, 89:115-124. 
 24.  Amura CR, Marek L, Winn RA, Heasley LE: Inhibited neurogenesis in JNK1-
deficient embryonic stem cells. Mol Cell Biol 2005, 25:10791-10802. 
 25.  Dong C, Yang DD, Wysk M, Whitmarsh AJ, Davis RJ, Flavell RA: Defective T cell 
differentiation in the absence of Jnk1. Science 1998, 282:2092-2095. 
 26.  Yang DD, Conze D, Whitmarsh AJ, Barrett T, Davis RJ, Rincon M, Flavell RA: 
Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2. Immunity 
1998, 9:575-585. 
 27.  Aouadi M, Binetruy B, Caron L, Le Marchand-Brustel Y, Bost F: Role of MAPKs in 
development and differentiation: lessons from knockout mice. Biochimie 2006, 
88:1091-1098. 
 28.  Krens SF, Spaink HP, Snaar-Jagalska BE: Functions of the MAPK family in 
vertebrate-development. FEBS Lett 2006, 580:4984-4990. 




 30.  Poulain M, Furthauer M, Thisse B, Thisse C, Lepage T: Zebrafish endoderm 
formation is regulated by combinatorial Nodal, FGF and BMP signalling. 
Development 2006, 133:2189-2200. 
 31.  Kunath T, Saba-El-Leil MK, Almousailleakh M, Wray J, Meloche S, Smith A: FGF 
stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent 
embryonic stem cells from self-renewal to lineage commitment. Development 2007, 
134:2895-2902. 
 32.  Yao Y, Li W, Wu J, Germann UA, Su MS, Kuida K, Boucher DM: Extracellular 
signal-regulated kinase 2 is necessary for mesoderm differentiation. Proc Natl Acad 
Sci U S A 2003, 100:12759-12764. 
 33.  Binetruy B, Heasley L, Bost F, Caron L, Aouadi M: Concise review: regulation of 
embryonic stem cell lineage commitment by mitogen-activated protein kinases. 
Stem Cells 2007, 25:1090-1095. 
 34.  Nichols J, Silva J, Roode M, Smith A: Suppression of Erk signalling promotes 
ground state pluripotency in the mouse embryo. Development 2009, 136:3215-3222. 
 35.  Villegas SN, Canham M, Brickman JM: FGF signalling as a mediator of lineage 
transitions--evidence from embryonic stem cell differentiation. J Cell Biochem 2010, 
110:10-20. 
 36.  Saba-El-Leil MK, Vella FD, Vernay B, Voisin L, Chen L, Labrecque N, Ang SL, 
Meloche S: An essential function of the mitogen-activated protein kinase Erk2 in 
mouse trophoblast development. EMBO Rep 2003, 4:964-968. 
 37.  Adams RH, Porras A, Alonso G, Jones M, Vintersten K, Panelli S, Valladares A, 
Perez L, Klein R, Nebreda AR: Essential role of p38alpha MAP kinase in placental 
but not embryonic cardiovascular development. Mol Cell 2000, 6:109-116. 
 38.  Allen M, Svensson L, Roach M, Hambor J, McNeish J, Gabel CA: Deficiency of the 
stress kinase p38alpha results in embryonic lethality: characterization of the kinase 
dependence of stress responses of enzyme-deficient embryonic stem cells. J Exp 
Med 2000, 191:859-870. 
 39.  Adams RH, Porras A, Alonso G, Jones M, Vintersten K, Panelli S, Valladares A, 
Perez L, Klein R, Nebreda AR: Essential role of p38alpha MAP kinase in placental 
but not embryonic cardiovascular development. Mol Cell 2000, 6:109-116. 
 40.  Guo YL, Yang B: Altered cell adhesion and cell viability in a p38alpha mitogen-
activated protein kinase-deficient mouse embryonic stem cell line. Stem Cells Dev 
2006, 15:655-664. 
 41.  Regan CP, Li W, Boucher DM, Spatz S, Su MS, Kuida K: Erk5 null mice display 
multiple extraembryonic vascular and embryonic cardiovascular defects. Proc Natl 
Acad Sci U S A 2002, 99:9248-9253. 
 42.  Krens SF, He S, Spaink HP, Snaar-Jagalska BE: Characterization and expression 
patterns of the MAPK family in zebrafish. Gene Expr Patterns 2006, 6:1019-1026. 
27 
 
 43.  Schier AF, Talbot WS: Molecular genetics of axis formation in zebrafish. Annu Rev 
Genet 2005, 39:561-613. 
 44.  Lepage SE, Bruce AE: Zebrafish epiboly: mechanics and mechanisms. Int J Dev 
Biol 2010, 54:1213-1228. 
 45.  Mathieu J, Griffin K, Herbomel P, Dickmeis T, Strahle U, Kimelman D, Rosa FM, 
Peyrieras N: Nodal and Fgf pathways interact through a positive regulatory loop and 
synergize to maintain mesodermal cell populations. Development 2004, 131:629-
641. 
 46.  Krens SF, He S, Lamers GE, Meijer AH, Bakkers J, Schmidt T, Spaink HP, Snaar-
Jagalska BE: Distinct functions for ERK1 and ERK2 in cell migration processes 
during zebrafish gastrulation. Dev Biol 2008, 319:370-383. 
 47.  Furthauer M, Van CJ, Thisse C, Thisse B: Fgf signalling controls the dorsoventral 
patterning of the zebrafish embryo. Development 2004, 131:2853-2864. 
 48.  Kudoh T, Wilson SW, Dawid IB: Distinct roles for Fgf, Wnt and retinoic acid in 
posteriorizing the neural ectoderm. Development 2002, 129:4335-4346. 
 49.  Londin ER, Niemiec J, Sirotkin HI: Chordin, FGF signaling, and mesodermal factors 
cooperate in zebrafish neural induction. Dev Biol 2005, 279:1-19. 
 50.  Anastasaki C, Rauen KA, Patton EE: Continual low-level MEK inhibition ameliorates 
cardio-facio-cutaneous phenotypes in zebrafish. Dis Model Mech 2012, 5:546-552. 
 51.  Furthauer M, Thisse C, Thisse B: A role for FGF-8 in the dorsoventral patterning of 
the zebrafish gastrula. Development 1997, 124:4253-4264. 
 52.  Furthauer M, Lin W, Ang SL, Thisse B, Thisse C: Sef is a feedback-induced 
antagonist of Ras/MAPK-mediated FGF signalling. Nat Cell Biol 2002, 4:170-174. 
 53.  Koshida S, Shinya M, Nikaido M, Ueno N, Schulte-Merker S, Kuroiwa A, Takeda H: 
Inhibition of BMP activity by the FGF signal promotes posterior neural development 
in zebrafish. Dev Biol 2002, 244:9-20. 
 54.  Krens SF, Corredor-Adamez M, He S, Snaar-Jagalska BE, Spaink HP: ERK1 and 
ERK2 MAPK are key regulators of distinct gene sets in zebrafish embryogenesis. 
BMC Genomics 2008, 9:196. 
 55.  Kim J, Lin JJ, Xu RH, Kung HF: Mesoderm induction by heterodimeric AP-1 (c-Jun 
and c-Fos) and its involvement in mesoderm formation through the embryonic 
fibroblast growth factor/Xbra autocatalytic loop during the early development of 
Xenopus embryos. J Biol Chem 1998, 273:1542-1550. 
 56.  Znosko WA, Yu S, Thomas K, Molina GA, Li C, Tsang W, Dawid IB, Moon AM, 
Tsang M: Overlapping functions of Pea3 ETS transcription factors in FGF signaling 
during zebrafish development. Dev Biol 2010, 342:11-25. 
28 
 
 57.  Holloway BA, Gomez de la Torre Canny, Ye Y, Slusarski DC, Freisinger CM, Dosch 
R, Chou MM, Wagner DS, Mullins MC: A novel role for MAPKAPK2 in 
morphogenesis during zebrafish development. PLoS Genet 2009, 5:e1000413. 
 58.  Wagner DS, Dosch R, Mintzer KA, Wiemelt AP, Mullins MC: Maternal control of 
development at the midblastula transition and beyond: mutants from the zebrafish II. 
Dev Cell 2004, 6:781-790. 
 59.  Gallo KA, Johnson GL: Mixed-lineage kinase control of JNK and p38 MAPK 
pathways. Nat Rev Mol Cell Biol 2002, 3:663-672. 
 60.  Habas R, Dawid IB, He X: Coactivation of Rac and Rho by Wnt/Frizzled signaling is 
required for vertebrate gastrulation. Genes Dev 2003, 17:295-309. 
 61.  Goldsmith EJ, Cobb MH, Chang CI: Structure of MAPKs. Methods Mol Biol 2004, 
250:127-144. 
 62.  Lee SJ, Zhou T, Goldsmith EJ: Crystallization of MAP kinases. Methods 2006, 
40:224-233. 
 63.  Chang CI, Xu BE, Akella R, Cobb MH, Goldsmith EJ: Crystal structures of MAP 
kinase p38 complexed to the docking sites on its nuclear substrate MEF2A and 
activator MKK3b. Mol Cell 2002, 9:1241-1249. 
 64.  Goldsmith EJ, Min X, He H, Zhou T: Structural studies of MAP Kinase cascade 
components. Methods Mol Biol 2010, 661:223-237. 
 65.  Wilson KP, Fitzgibbon MJ, Caron PR, Griffith JP, Chen W, McCaffrey PG, 
Chambers SP, Su MS: Crystal structure of p38 mitogen-activated protein kinase. J 
Biol Chem 1996, 271:27696-27700. 
 66.  Zhang J, Zhang F, Ebert D, Cobb MH, Goldsmith EJ: Activity of the MAP kinase 
ERK2 is controlled by a flexible surface loop. Structure 1995, 3:299-307. 
 67.  Canagarajah BJ, Khokhlatchev A, Cobb MH, Goldsmith EJ: Activation mechanism of 
the MAP kinase ERK2 by dual phosphorylation. Cell 1997, 90:859-869. 
 68.  Cobb MH, Goldsmith EJ: How MAP kinases are regulated. J Biol Chem 1995, 
270:14843-14846. 
 69.  Dimitri CA, Dowdle W, MacKeigan JP, Blenis J, Murphy LO: Spatially separate 
docking sites on ERK2 regulate distinct signaling events in vivo. Curr Biol 2005, 
15:1319-1324. 
 70.  Goldsmith EJ: Three-dimensional docking in the MAPK p38alpha. Sci Signal 2011, 
4:e47. 
































Generation of Constitutive Active ERK 
Mutants as Tools for Cancer Research in 
Zebrafish 
Hanan Rian, S. F. Gabriel Krens, Herman P. Spaink, and B. Ewa Snaar-Jagalska 






























The extracellular-signal-regulated-kinase (ERK) signaling pathway is essential for 
vertebrate development and is frequently deregulated in human, and zebrafish 
tumors. Previously, we cloned and characterized the zebrafish MAPK gene-family 
and showed that ERK2 is crucial for cell migration and early zebrafish 
embryogenesis. To further study ERK2 function we generated constitutively active 
mutant forms of the ERK proteins by introducing conserved point mutations. We 
validated the enhanced protein activity in vitro by transfection of constructs into 
zebrafish zf4 cells and demonstrated elevated phosphorylation levels of 
downstream targets p90RSK, CREB and MNK1, by ERK2L84P/S162D and 
ERK2L84P/S162D/D330N specifically. In vivo validation was performed by ectopic 
expression of corresponding mRNAs in the transgenic zebrafish FGF-ERK2 reporter 
fish line Tg(Dusp6:d2EGFP). Both mutant ERK2 isoforms induced elevated 
transgene expression compared to ERK2WT, confirming increased kinase activity in 
vivo. 
Phospho-kinomic analysis on peptide microarrays was performed to identify new 
targets in embryos injected with FGF8 or ERK2L84P/S162D/D330N mRNAs. We detected 
both FGF8 specific and common signalling targets. Interestingly, with both mRNAs 
we found increased phosphorylation levels of CDK1, which is critical for proper 
G2/M phase transition and mitotic entry in proliferation control. These results 
corroborate that constitutive activation of the ERK2 pathway leads to enhanced, 













Introduction   
The mitogen-activated protein (MAP) kinases extracellular signal-regulated kinase 1 
and 2 (ERK1 and ERK2) are crucial components of the regulatory machinery 
underlying normal and malignant cell proliferation. The rat sarcoma (RAS)/ rapidly 
accelerated fibrosarcoma (RAF)/ MAPK kinase (MEK)/ERK oncogenic pathway is 
induced by various growth factors and forms a convergence point of multiple 
signaling pathways to control essential cellular processes including migration, 
differentiation, growth and survival [1-5]. Approximately 30% of all human cancers 
display evidence of enhanced activation of the RAS/RAF/MEK MAPK pathway [6]. 
The pathway has been extensively studied in relation to tumor formation and this 
was greatly facilitated by the availability of constitutively active forms of RAS, RAF 
and MEK [7,8]. Expression of oncogenic RAS as well as constitutive active forms of 
RAF and MEK can lead to induced tumorigenic transformation of NIH 3T3 cells 
[9,10]. In addition, in vivo studies with transgenic mice models, expressing 
constitutive active MEK in the heart, lens chondrocytes or skin, displayed increased 
cell numbers or cell size and a delayed onset of cell differentiation [11]. Melanoma 
is a form of cancer with an extremely high frequency of deregulated RAF/MEK/ERK 
as 70% of the melanoma cases harbour increasing activity mutations in the RAF 
oncogene [12]. The activating mutation in B-RAF (BRAFV600E) found in human 
nevi drives generation of nevi in zebrafish when expressed in melanocytes. Coupled 
with the loss of the tumor-suppressor gene p53, nevi progress from benign clusters 
of melanocytes to malignant melanoma [13,14]. This indicates that pathology and 
molecular mechanisms of tumor formation between humans and zebrafish are 
similar and providing molecular tools for the establishing zebrafish cancer models 
for a better understanding of different pathogenesis [15-19].The same signaling 
pathways that orchestrate embryonic development are frequently deregulated 
during tumor progression. In fact these signaling pathways appear to add 
significantly to the aggressiveness of tumors. Proteins critical in embryogenesis can 
be reactivated in adult cells and play a role in allowing tumor cells to overcome 
barriers and to metastasize [20-22]. Recent studies in our laboratory have 
demonstrated that depletion of ERK2 in zebrafish disturbs cell migration 
mechanisms and causes developmental arrest in an early embryonic (blastula) 
stage. Although the apparent ERK1/2 gene expression levels appear to be constant 
during all stages of early zebrafish development, differences in ERK1/2 signal 
activity is first detected with whole mount immunohistochemistry in the enveloping 
layer (EVL) of the early blastula [23]. During epiboly ERK1/2 activity is induced at 
the margin by fibroblast growth factor (FGF) morphogens and controls convergent 
extension cell movements and mesoderm differentiation [23].  
We expect that overactivation of ERK2 will increase the proliferation and migration 
properties of cells in the developing embryo, leading to aberrant developmental 
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programm and perhaps tumor formation. In this study we aim to focus on the 
ERK/MAPK level of the oncogenic RAS/RAF/MEK/ERK cascade by constructing 
zebrafish constitutive active mutants that are independent of negative feedback 
signaling and use these tools to understand the downstream molecular mechanisms 
that are involved in developmental processes, which also play a role in converting 
normal to uncontrolled cell proliferation. These results illustrate that zebrafish is a 
powerful vertebrate model that allows simultaneous study of embryonic 
development and tumor progression using multidisciplinary approaches.  
 





Plasmid transformation and isolation  
Transformation of DNA constructs was performed by adding 0,5 μl DNA to 50μl one 
shot TOPO 10F’ competent E.coli cells (Invitrogen). The transformed cells were 
cultured on ampicilline LB agar plates (Luria-Bertani broth 1.5% agar 100mg/ml 
ampicilline) and the constructs were isolated with the Nucleobond Xtra midi/maxi 
plasmid DNA purification kit (Clontech laboratories inc).  
 
Site directed mutagenesis  
The Amino acid substitutions of interest in zERK1 and zERK2 were generated by 
site directed mutagenesis using the QuikChange(R) site directed mutagenesis kit 
(Stratagene). Primers (Sigma-Aldrich) were designed according to the guidelines of 
the supplied protocol and used for the mutagenesis reaction (Table1). A forward 
Table1: Primer list for site directed mutagenesis. 
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and reverse primer is designed for each mutation. The primers (forward and 
reverse) overlap the mutation and have minimal 10 residues at each side of the 
mutation. The nucleotides complementary to the mutation site are changed to 
generate the desired substitutions. The four reaction steps of the site directed 
mutagenesis kit were performed with 10ng PCS2+zERK1 or PCS2+zERK2 DNA. 
Double and triple mutants were generated by repeating the four steps of the 
mutagenesis reaction with the single and double mutant DNA templates 
respectively. The Leucine to Proline substitution was generated by replacing CTC to 
a CCC codon in ERK1 and CTG to CCG in ERK2; the Serine to Aspartic acid 
substitution by replacing the TCA to GAC in both ERK1 and ERK2. Finally, the 
Aspartic acid to Aspargine substitution was obtained by GAT to AAT replacement in 
zERK1 and zERK2. Importantly, no other residues than the one of interest were 
found mutated. Sequencing analysis confirmed the successful introduction of all 
mutations. Importantly, no other residues than the one of interest were found 
mutated. 
Transfection of PCS2+ERK1/2 (mut) in zf4 cells  
The transfection experiments were performed with the FuGene HD transfection 
reagent (Roche). A transfection mix containing 1,5 μg construct DNA, the FuGene 
reagents and plain medium (without FCS) was applied to a confluent layer of cells in 
0,5ml medium and incubated for 6h. To allow the cells to recover 1,0ml medium with 
FCS was added for overnight incubation. PCS2+ERK1 and PCS2+ERK2 (mutated) 
constructs were transfected in zf4 cells and after recovery starved for 6 ½ hour. The 
protein was isolated directly after starvation in 1X SDS sample buffer (Red Loading 
Buffer Pack 1723 Cell Signaling Technology(R)).  
 
mRNA synthesis  
The PCS2+ERK2_WT PCS2+ERK2* PCS2+ERK2** and PCS2+ERK2*** 
constructs were linearized with Apa1 prior mRNA synthesis with the mMessage 
mMachine kit (Ambion). 1 μg of the purified digest was used for the mRNA 
synthesis reaction with Sp6 RNA polymerase. Subsequently, 1 μl of Dnase was 
added to the reaction which is incubated for 30 min at 37 ºC. The mRNA samples 
were purified with the NucleoSpin RNA Clean-up kit (Nucleobond) and analysed by 
electrophoresis on a 1% Rnase-free agarosegel.  
 
Microinjection in zebrafish embryos  
1.0 nl ERK (mutant) mRNA (50ng/μl) was injected into one-cell stage 
Tg(Dusp6:d2EGFP) zebrafish embryos. Injected embryos were used for protein 






Protein isolation from zebrafish embryos 
(Injected) embryos of 5hpf where mechanical dechorionated and kept until protein 
isolation in agarose coated wells filled with 1X Danieau buffer. For isolation embryos 
were disrupted in Ca2+/Mg2+ free solution and cells were subsequently washed with 
PBS. 1µl/embryos of 1X lysis buffer (1M Tris-Hcl pH7,4, 0,5M EDTA, 1 tablet 
protease inhibitor, 0,1M Na3VO4, 0,5M NaF)  was added. 2ug protein from 
zebrafish embryos was used for western blotting.  
 
Western blotting  
Protein samples were loaded on a 10%acrylamide PAGE gel. The high range 
rainbow molecular weight marker (RPN756V, Amersham Biosciences) was used for 
band size determination. After blotting on a nitrocellulose membrane the blot was 
incubated with 1:1000 diluted Phospho-p90RSK Thr573 (9346), Phospho-p44/42 
MAP Kinase Thr202/Tyr204 (9101), p44/42 MAP Kinase (9102), Phospho-Elk-1 
Ser383 (9181), Phospho-CREB Ser133 (9198), Phospho-Mnk1 Thr197/202 (2111), 
and phospho-p90RSK Ser380 (9341) rabbit antibody (Cell Signaling technology(R)). 
The ECL western blotting detection reagents and analysis system (Amersham 
Biosciences) was used for chemoluminescence detection with secondary antibody 
the ECL™-HRP Linked Antirabbit IgG (Amersham). The blots are stripped with 
Western-Re-Probe™ Reagent (G-Biosciences) for re-staining.  
 
Serine Threonine kinome profiling  
Protein samples were prepared as described above except M-PER lysis buffer with 
phosphatase and protease inhibitors (PIERCE) was used. Samples were 
snapfreezed in liquid nitrogen and delivered to PamGene International BV for 
analysis. 1µg of each lysate was loaded on PamChip® arrays, with 144 immobilized 
peptide substrates in a porous ceramic membrane, and incubated in the presence 
of 400µl ATP. Functional readout is based on kinetic measurement of Ser/Thr 
phosphorylation occurring on the array using fluorescently labelled anti-phopho-
antibodies. Data processing including image quantification, quality control, statistical 















Conserved constitutive activating mutation sites in ERK2 orthologues over different 
evolutionary phyla.   
Previous large scale mutation screens of the Drosophila melanogaster gene rolled 
and Saccharomyces cerevisiae gene fus3 have facilitated the construction of the 
constitutive active rat orthologue ERK2 [24]. Three point mutations (L73P, S151D 



















Fig1: Overlap of homology predicted protein models showing the active (grey) and 
inactive (white) zebrafish ERK2 protein structure . Phosphorylation of the dual 
phosphorylation site (TEY) causes structural rearrangement of the activation lip. The 
substitutions may cause rearrangements of intermolecular interactions between amino acids 
resulting in a smaller distance between the activation lip with the TEY motif and the catalytic 
site and facilitating autophosphorylation. The L83P site (blue) is located in α-helix C and 
S162D (green) in the catalytic loop, both in the active site of the kinase. The D330N (red) 
mutation is located in the CD-site which is a docking site for inhibitory phosphatases. The 
D330N substitution prevents ERK inhibitory phosphatases to bind. The atomic resolution 
models of zebrafish ERK2 were constructed with the zERK2 amino acid sequence 
(ENSAMBLE:ENSDARP00000038550) and based on three dimensional X-ray crystallography 
predictions PDB:1ERK and PDB:2ERK (phosphorylated). Homology modelling was performed 
using free online Swiss-model and models were illustrated with Chimera. 
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wild type rERK2 when introduced simultaneously. In addition, the L73P/S151D 
double mutant was 50-fold more active as detected in the in vitro test where the 
rates of phosphoryl transfer from [-32P] ATP to myelin basic protein were measured 
in 10-min assays. The mutations enhance ERK2 activity most likely by facilitating 
intramolecular autophosphorylation predominantly at Tyr-185 and to a lesser extent 
at Thr-183. As in the wild type, phosphorylation at both sites is required for full 
activation of ERK2 [24]. Considering the high conservation of MAPKs in vertebrates, 
these point mutations could possibly activate the zebrafish orthologue of rat ERK2 
and since ERK1 and ERK2 are 90% identical the same mutations may also activate 
zERK1.  Multiple alignment including the amino acid sequence of FUS3, ROLLED, 
rat ERK2 and zebrafish ERK1 and ERK2 showed an evolutionary conservation of 
the L73P, S151D and D319N mutation sites (Table2) [24-26]. The homology model 






The mutations that were found to activate rERK2 were introduced into 
pCS2+zERK1 and pCS2+zERK2 constructs by site directed mutagenesis. To 
determine whether single mutation or a combination of two or three mutation(s) 
would increase zERK activity we constructed single, double and triple mutants of 
both zERK1 and zERK2. Altogether six potential constitutive active ERK mutants 
were obtained; zERK1L106P, zERK1L106P/S184D, zERK1L106P/S184D/D352N, zERK2L84P, 
zERK2L84P/S162D and zERK2L84P/S162D/D330N.  
 
 
Table2: MAPK activating mutations. * Single mutant, ** Double mutant, *** Triple 






















ERK2 double and triple mutants phosphorylate downstream targets in vitro despite 
growth factor deprivation.  
In cells transfected with ERK2 double and triple mutants substrate phosphorylation 
is enhanced in vitro, in the absence of growth factors.  To compare the activity of 
ERK mutants and wild type (wt) proteins we performed a biochemical 
characterization experiment after transfection of corresponding plasmids into 
cultured zf4 cells (Fig2). The transfected cells were starved for 6½ h in cell culture 
medium without of FCS before protein isolation. Since the MAPK/ERK pathway is 
Fig2: Western blot detection of ERK1/2, P90RSK, and CREB phosphorylation in zf4 
cells transfected with PCS2+ERK1 and PCS2+ERK2 (mutated) constructs. A Western 
blotting was performed with total ERK and dpERK. The Ectopic ERKs derived from 
synthetic mRNAs have a greater MW than the endogenous ERKs due to the introduction 
of a small linker, and can therefore be distinguished by size. The bands with higher 
molecular mass were also detected with anti-ERK1/2 antibody in cells transfected with 
ERK
TEY
 mutants but not with the anti-phspho-ERK1/2 antibody. This confirms that the 
bands with higher molecular weights are from the transfected ectopic ERK. B Western blot 
detection of phospho-p90Rsk with two different antibodies one targeted against Thr573 
and another against Ser380. C Western blot detection with the phospho-Creb Ser133 
antibody which cross-reacts with phospho-ATF. D Band intensities were measured for 
quantification of western blots (A-C) dp-ERK(ectopic) p-P90RSK and p-CREB band 
intensities were corrected for total ectopic ERK synthesis. Mutants were normalized 
against ERK1-WT or ERK2-WT. WT: protein samples from zf4 cells transfected with 


















 0: untransfected zf4 cells, EGFP: zf4 cells 
transfected with pcs2+EGFP. 
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known to be induced by growth factors we expected the activity of endogenous and 
ectopic ERK to be decreased to basal levels by starvation, enabling us to compare 
downstream signalling between wt and mutant ERK proteins. Subsequent western 
blotting with antibodies against total ERK showed that all transfected zebrafish 
ERK1 (data not shown) and ERK2 constructs were expressed in zf4 cells (Fig2a). In 
addition to the band of endogenous zERK, visible in all samples, a second band 
was detected in protein samples of ERK1 and ERK2 transfected cells but not in the 
control untransfected cells and the cells transfected with PCS2+eGFP. The extra 
bands have the exact molecular mass of the ectopic zERKs which are modified to 
have a 1,66 and 1,23 kD higher molecular mass then the endogenous zERK1 and 
zERK2 respectively. The bands of ectopic zERK1 (data not shown) and zERK2 
were also visible after detection with antibody against phosphorylated ERK1/2 in 
samples of the ERK transfected cells. To be able to detect differences in the degree 
of target phosphorylation between mutant and wild type zERKs, antibodies against 
phosphorylated p90 ribosomal S6 kinase (p90RSK), cAMP response element-
binding protein (CREB) and MAP kinase-activated protein kinase (MNK1) were 
used (Fig2b-e). Western blotting quantification and subsequent correction for 
ectopic ERK synthesis and normalization against wt ERK confirms the increased 
phosphorylation of the triple mutants of both ERK1 and ERK2. For the detection of 
phosphorylated p90RSK, two different antibodies were available, that cross reacted 
with the zebrafish ortologue, directed against distinct sites targeted by ERK. With 
both antibodies an increased phosphorylation of p90RSK was found in cells 
transfected with the double and triple mutants of zERK2 only when compared to 
cells with wt ERK1/2 overexpression. In addition, phosphorylation increase of the 
other ERK targets CREB and MNK1 was detected in the zERK2 double and triple 
mutant samples. No increase of either phosphorylated p90RSK, CREB or MNK1 
was detected in cells transfected with wt or mutated ERK1 (data not shown).  
 
CA-ERK2 and FGF8 induce transgene expression of Tg(Dusp6:d2EGFP). 
Synthesized ERK2 wt and mutant mRNA was injected in 1-cell stage zebrafish 
embryos for in vivo validation of constitutive activation. Ectopic phosphorylated ERK 
was detectable in proteins samples collected at 5hpf with western blotting (Fig3a). 
In addition, the ERK2 triple mutant was significantly more phosphorylated and the 
double mutant was slightly increased compared to the ectopic wt ERK2 and the 
ERK2 single mutant. Therefore we continued the validation of the double and triple 
ERK2 mutants in vivo, based on an ERK2 negative feedback mechanism, involving 
the downstream gene target dual specificity phosphatase (DUSP6) in 
Tg(Dusp6:d2EGFP) (Fig3b). The FGF8 morphogen induces ERK activity at the 
dorsal site and the margin of the zebrafish embryo during epiboly. Subsequently 
ERK2 induces the expression of DUSP6 which is a dual specificity phosphatase that 
removes both activating phosphates of the ERK2 (Thr-Glu-Tyr) motif [27]. When 
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FGF8 mRNA was injected in Tg(Dusp6:d2EGFP) embryos the GFP signal 
increased and shifts from the dorsal site to the entire animal pole (Fig3b).  Batches 
 
Fig3: In vivo ERK signaling activity analysis of ectopically expressed FGF or ERK 
isoforms. A western blot detection of dpERK on protein samples isolations from 5hpf 
embryos injected with 50pg WT or mutant ERK2 mRNA and isolated. B flowchart of the 
experimental procedure using the Tg(Dusp6:d2EGFP) and subsequent COPAS XLUnion 
Biometrica.analyis C. 5hpf old living embryos are passed through the COPAS flowcell and 
optical density/axial length (blue), GFP (green), YFP (yellow) and dsRED (red) 
fluorescence profiles are recorded Union Biometrica, Inc. D. Peak Height values (PH) of 
the GFP channel were collected for ERK2_WT, ERK2**, ERK2*** and FGF8 mRNA 
injected embryos, after corrected for auto-fluorescence/background of non-injected wild 
type embryos (see methods), and plotted in a bar graph as the mean value of three 
biological experiments, each with a minimum of 30 embryos/condition. Mean GFP PH 
values are normalized against ERK2_WT. Arrow bares represent standard deviations of 
the means of the three biological experiments, p-values were calculated by plying a t-
test with Welch-correction. 
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of Tg(Dusp6:d2EGFP) embryos were injected with wt ERK2, ERK2 double mutant,  
triple mutant and FGF8 mRNA and analyzed with the COPAS XL which performs 
large scale GFP fluorescence detection of live embryos. Both mutants as well as 
FGF8 increased the eGFP signal in heterozygous Tg(Dusp6:d2EGFP) embryos at 
5hpf (Fig3c). 
 
Kinome profiling reveals increased phosphorylation of the cell cycle progression 
protein CDK1 as a consequence of FGF8 and CA-ERK2 overexpression in 
zebrafish embryos.  
To identify substrates that are in particular affected by ERK constitutive activation 
we performed a serine threonine phospho-kinome peptide array experiment 
comparing lysates of ERK2***, ERKWT and FGF8 injected embryos against an 
uninjected control. 111 peptides where phosphorylated by the zebrafish lysates and 
with model based clustering 7 clusters were distinguished from this pool (Fig4a). 
Cluster 1 comprises peptides which are less phosphorylated due to FGF8 
overexpression (supplementary Fig1a) while 
cluster 2 is showing the opposite effect of 
FGF8 specific targets which are increasingly 
phosphorylated (Fig4b and Table 3). Cluster 
3 and 4 represent peptides with decreased 
and increased phosphorylation respectively 
as a result of wt ERK2 overexpression. This 
might be the effects of negative feedback as 
a consequence of ERK overexpression that 
have less or no effect on the mutant. Cluster 
5 and 7 are less phosphorylated peptides due 
to overactivation of the FGF-ERK pathway or 
due to injection. Cluster 6 consist of an 
interesting group of peptides which are 
increasingly phosphorylated by both FGF8 
and the ERK2*** mutant (Fig4c and Table4). 
The proliferation marker CDK1 (CDC2) is 
found among the cluster 6 peptides of which 
phosphorylation within amino acids 154-169 
is significantly induced by FGF8 and ERK*** 
(p-value<0,05) compared to uninjected 
embryos.  
Fig4: Kinome profile clustering of embryos ectopically expressing ERK2WT, 
ERK2 triple mutant and FGF8. Simplified representation of FGF-ERK signalling 
pathways to downstream specific target clusters (up). Clusters are based on a 
Bionavigator based clustering algotithm,that groups peptides into clusters according to 
treatment-based response similarities (down). AKT is Protein Kinase B (PKB), PLCγ is 











Three point mutations, that already were shown to activate rat ERK2, were 
sequentially introduced in zERK1 and zERK2 providing us with six mutants to be 
tested for increased activation [24]. The six mutants include the single mutants 
zERK1L106P and zERK2L84P, the double mutants zERK1L106P/S184D and zERK2L84P/S162D 
and finally the triple mutants zERK1L106P/S184D/D352N and zERK2L84P/S162D/D330N. The 
Western blot results with total and dpERK antibodies show that all mutants were 
successfully expressed and phosphorylated in zf4 cells. In addition, Western blot 
analysis with dp-ERK after transfection of zf4 cells as well as mRNA injection in 
zebrafish embryos clearly showed increased TEY phosphorylation of zERK1 and 
zERK2 triple mutants (Fig2a). Comparison to the wild type isoforms of the proteins 
shows that the ERK2 double mutant induced a slight increase in signaling to 
downstream targets, despite the poorly detectable increase of its TEY 
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phosphorylation in transfected zf4 cells. Strikingly, the triple mutant of ERK2 
revealed clear hyper- phosphorylation of ERK substrates p90RSK, CREB and 
MNK1 (Fig2). This could have been a detection discrepancy of this assay as the 
double mutant appears to be indeed more phosphorylated at its dual 
phosphorylation site in zebrafish embryos (Fig3a). In the absence of growth factor 
stimulation zERK2L84P/S162D and zERK2L84P/S162D/D330N maintained activity and 
phosphorylation of substrates in zf4 cells. We therefore continued investigation the 
constitutive active ERK2 double and triple mutants in heterozygous 
Tg(Dusp6:d2EGFP) at 5hpf and included FGF8 as a positive control. eGFP 
induction after FGF8 mRNA injection was demonstrated previously by Molina et al  
using fluorescent microscopy [28]. We were able to quantify increased eGFP 
fluorescence in batches of minimal 30 FGF8 mRNA injected embryos with the 
COPAS XL (Fig3). During zebrafish epiboly FGF8 acts as a morphogen which 
induces the MEK/ERK pathway at the margin were it regulates the gene expression 
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of DUSP6 [29]. Therefore along with FGF8 we injected the ERK2 WT, double and 
triple mutants for in vivo quantitative fluorescent detection and conclude that the 
ERK2 double and triple mutants are more potent to induce downstream gene 
expression than the WT form. For the next experiment we proceeded further with 
the ERK2 triple mutant because the in vivo monitored increase in activity was more 
significant than that of the double mutant. In addition to the two substitutions that 
facilitate auto-phosphorylation, the triple mutant contains an extra substitution in the 
phosphatases interacting motif which prevents inactivation of ERK2 by feedback 
signaling, resulting in the highest phosphorylation activity level for the triple mutant 
isoform.  
 
The fibroblast growth factors are known to bind to their corresponding tyrosine 
kinase receptors and that relay the extracellular signals further to the ERK/MAPK 
pathway and the PI3/AKT pathway. Therefore, part of FGF downstream signaling 
should overlap with ERK2 downstream signaling. To identify this pool of substrates 
in zebrafish cell lysates isolated from 5 hours old embryos, using PamGene serine 
threonine kinome peptide arrays (Fig4). Kinome profiles of embryos injected with 
FGF8, wt ERK2 and ERK2 triple mutant mRNA were compared against uninjected 
wt with model based clustering. The 7 clusters of peptides were identified of which 
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cluster 6 represents the overlapping pool of peptides induced by FGF8 and ERK2 
triple mutant and cluster 2 the FGF8 targets independent of ERK/MAPK signaling.  
However the fold induction of phosporylation of each peptide compared to the 
uninjected control was quite low and often did not exceed the variation between the 
biological triplicates and therefore we could not demonstrate its significance using 
statistical tests. This is possibly due to the endogenous ERK2 signaling already 
present in the cell lysates. Despite this difficulty we found phosphorylation on the 
154-162 amino acids of the peptide corresponding to the cell proliferation marker 
CDK1 (CDC2), to be significantly increased in embryo lysates overexpressing 
ERK2*** and FGF8. Direct interaction of active ERK2 with CDC2/CDK1 has not 
been demonstrated before, but, both kinases are key players in cell cycle regulation 
and known to promote G2/M transition and proliferation. In response to mitotic 
stimulation ERK2 is known to induce expression of cyclin D, which binds and 
activates CDK4 and CDK6. In addition, activated ERK2 increased the expression of 
cyclin A, which binds to either CDK1 or CDK2 [30]. The cyclinA/B-CDK1 complex 
becomes fully functional after dephosphorylation of inhibitory Tyr15 and Thr14 
residues and phosphorylation of Thre-161 on CDK1 by Cdk Activating Kinases 
(CAK) [31,32]. The molecular mechanism connecting ERK2 and CAK, leading to 
increased thr-161 phosphorylation of CDK1, remains to be identified.   
 
Conclusion 
In this study we have successfully constructed two constitutive active zebrafish 
ERK2 mutants zERK2L84P/S162D and zERK2L84P/S162D/D330N which continue to drive 
downstream signaling during growth factor deprivation in vitro and which are more 
potent to relay signals to the nucleus and induce target gene transcription in vivo. In 
addition, cell proliferation can be induced by zERK2L84P/S162D/D330N as elevated ERK2 
signals increase the phosphorylation of CDK1, a key protein involved in promoting 
cell cycle progression. Future research will be focusing on the possible long term 
effect of constitutive ERK2 activation by developing transgenic zebrafish lines that 
drive constitutive active ERK2 isoforms under the control of the melanocyte-specific 
promotors mitfa or kita. Analysis of the specific downstream molecular mechanisms 
that are involved in oncogenic transformation will attribute to the specific role of 
MAPK signaling, when compared to other systems such as the BRAF 
(BRAFV600E) transgenic fish line. 
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Characterization and expression analysis 
of two novel zebrafish P38 isoforms 































The P38 MAPK subfamily consists of four isoforms (P38α, P38β, P38γ, and P38δ) 
that play a role in proliferation, differentiation and stress responses. P38 signaling is 
found to be deregulated in pathologies like Alzheimer, cancer, rheumatoid arthritis 
and asthma.  
The Zebrafish orthologs of most MAPK genes have recently been identified, 
however two isoforms of the p38 family remained to be detected. In this study, two 
novel zebrafish p38 (β, δ) cDNAs were cloned, which translated into 361 and 362 
amino acid proteins, respectively, with approximately 56% identity. Comparison of 
the amino acid sequences of all zebrafish P38 MAPKs by multiple sequence 
alignment indicated conservation of the dual phosphorylation site TXY motif, DFG 
site, ED site and CD domain in all zebrafish P38 isoforms. The catalytic region, with 
the glycine-rich loop, hinge region and α-Helix C, is more than 83% identical 
between the P38α and P38β isoforms. Mutation prone residues are mainly localized 
at the MAP Kinase insert and α-Helix G. Semi-quantitative reverse transcriptase-
PCR revealed an ubiquitous expression pattern of zebrafish p38β throughout 
embryogenesis, whereas p38δ levels were variable. Unlike p38δ, p38β was 
maternally expressed and both genes were expressed in the adult zebrafish.  To 
localize the expression whole mount in situ hybridization was performed from 1- to 
5- dpf. p38β mRNA was detectable in the heart, lens, notochord and the 
telencephalon, diencephalon, presumptive forebrain ventricle, the midbrain 
tegmentum, mid-hindbrain boundary and rhombencephalon of the brain. P38δ was 
aslo expressed in the notochord, the telencephalon, diencephalon, midbrain 
tegmentum and rhombomeres of the hindbrain. In addition p38β mRNA was 
concentrated in the chondrocranium, pectoral fins, neural retina, the gut and at 
somite boundaries.  
Phylogenetic analysis revealed that zebrafish p38 isoforms cluster with their 
corresponding orthologues in human, mice, rat, Xenopus and medaka. Like in 
mammals, the zebrafish P38α and P38β are the most similar isoforms. 
Altogether, this study reports the identification of two novel zebrafish P38 isoforms 
and the analysis of their specific spatial and temporal expression patterns during 








The four mammalian P38 MAPKs, α(MAPK14), β(MAPK11), γ(MAPK12) and 
δ(MAPK13) are representative MAPKs of one of the three main subfamilies of the 
Mitogen Activated Protein Kinases (MAPK). The other two subfamilies are the 
extracellular-signal regulated protein kinases (ERK) and the c-Jun amino terminal 
kinases (JNK). MAPK family is conserved in evolution through the plant and animal 
kingdom and constitutes one of the major eukaryotic signalling families that transmit 
extracellular signals from the cell-surface to the nucleus. They contribute to the 
ability of cells to receive and respond to environmental cues. The repertoire of their 
substrates includes cytoskeleton proteins as well as transcription factors controlling 
global gene expression (Johnson, Lapadat, 2002; Kim, Choi, 2010; Roux, Blenis, 
2004). These proteins have been implicated in numerous cellular functions including 
cell growth, migration, proliferation, differentiation, survival and development, and 
mis-regulated MAPK signaling has been engrossed in many human diseases. 
The three subfamilies are distinguished according to the middle amino-acid residue 
of the conserved Thr-Xxx-Tyr (TXY) dual-phosphorylation motif with TGY being 
specific for the P38 subfamily. Phosphorylation of the TXY motif activates MAPKs 
and occurs by upstream MAPKK which in turn are activated by MAPKKK. MAPKK 
undergo a highly selective interaction with specific MAPKs which could be explained 
by structural differences of the activation loop containing the TXY motif. MAPKK3 
and MAPKK6 interact specifically with the P38 subfamily whereas MAPKK4 binds to 
the P38α isoform and to JNK MAPKs facilitating crosstalk between these two 
subfamilies (Zarubin, Han, 2005; Cuadrado, Nebreda, 2010).  
The P38 family was initially associated with stress responses since the first 
identified isoform Hog1/P38α in yeast was rapidly phosphorylated after LPS 
stimulation or hyper osmotic shock. Additionally, P38α activation in higher 
eukaryotes is stimulated by stress factors such as heat, pro-inflammatory cytokines, 
UV irradiation etc (Fearns et al. 2000). In response to these stimuli P38α regulates 
cellular protective mechanisms including the biosynthesis of pro-inflammatory 
cytokines (IL-1, IL-6, IL-8, TNFα, COX-2 and IFN-γ) and inhibits the anti-
inflammatory and immunosuppressive activities of the glucocorticoid receptor (Lee 
et al. 1994; Wang, 2004). In addition, the P53 tumor supressor is among the P38α 
substrates providing a link with the cell cycle checkpoints (Thornton, Rincon, 2009). 
The P38 subfamily is often found to play a key role in the pathogenesis of disorders 
such as cancer, rheumatoid arthritis, asthma and Alzheimer, which are a 
consequence of aberrant functioning of cell cycle progression and immune or 
inflammatory responses (Coulthard et al. 2009; Cuenda, Rousseau, 2007; Chung, 
2011; Munoz, Ammit, 2010) .            
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Many studies have been performed using the pyridinyl imidazole inhibitors 
SB203580 and SB202190 which inhibit P38α and β equally, with no significant 
effect on γ and δ, therefore knowledge on the functional distinction between these 
two isoforms is elusive. The essential role of the P38α isoform in development was 
demonstrated in knock-out mice resulting in homozygous embryonic lethality 
caused by severe defects in placental angiogenesis (Mudgett et al. 2000). In 
contrast, mice lacking P38β, P38γ and P38δ were viable, fertile and did not show 
any obvious phenotypes.  
Although all P38 isoforms are activated by environmental stress and pro-
inflammatory cytokines, P38α is suggested to be the main isoform regulating 
cytokine production. Mice lacking p38β showed no defects in the cytokine 
production or immune function after LPS stimulation or after crossing with a mouse 
line ectopically expressing the systemic cytokine TNFα (Beardmore et al. 2005). 
Nevertheless a specific metabolic role of P38β has been reported in the regulation 
of the mTORC1 pathway during energy stress involving intracellular ATP depletion 
(Kalender et al. 2011). Antagonistic roles of the P38 isoforms were demonstrated, 
for example P38δ has an opposing role in P38α induced activation of the 
osmoprotective transcription factor TonEBP/OREBP in HEK293 cells treated with 
high concentrations of NaCl (Zhou et al. 2008; Pramanik et al. 2003). In addition, 
P38δ plays a specific role in the regulation of skin homeostasis and tumorigenesis 
(Eckert et al. 2003; Schindler et al. 2009).  
As previously described (Krens et al. 2006a), the zebrafish genome encodes for 
members of all MAPK subfamily: ERK, JNK and p38 and the functions of ERK1/2 
and JNK in embryogenesis are intensively studied (Krens et al. 2006b).  However, 
only a few reports have investigated the role of p38 family in zebrafish.  Ectopic 
expression by injection of a dominant negative (DN) form of p38α indicated that 
asymmetric distribution of p38α activation contributes to symmetric and 
synchronous cell cleavage (Fujii et al. 2000). Furthermore, DN p38α phenocopies 
the betty boop (MAPKAPK2) mutant phenotype by inducing premature constriction 
of the blastoderm margin, in a YSL specific manner in zebrafish pre-gastulation 
embryos (Holloway et al.2009).   
In this study we report the cloning and characterization of novel members of the p38 
subfamily p38β and p38δ and describe their spatial and temporal expression 






Material & Methods 
Zebrafish husbandry 
Zebrafish (Danio rerio) wild type line was maintained under standard conditions and 
guidelines given in the zebrafish book (Westerfield 200). Embryos were kept at 
28.5°C and staged in hours post fertilization (hpf) according to (Kimmel et al. 1995). 
 
3.2 cDNA synthesis and Cloning of p38 β/δ genes 
Total RNA was isolated from adult Teubingen zebrafish, using Trizol Reagent 
protocol (GIBCOBRL, Life technologiesTM). cDNA synthesis was performed with 
iScript™ cDNA Synthesis Kit (Bio-Rad) and was amplified with Phusion® High-
Fidelity DNA Polymerase and gene specific primers of P38β fw: 5’ 
CGGAAAACATGGCGACAAGAC 3’ rv: 5’ TGCGCTCAGTTTTATTGTTCAACC 3’ 
and p38δ fw: 5’ CTAAATGGAGTCTCGGGTGG 3’ rv: 
CTAGGACATGGTGAGTGAGTGTGTT. Subsequently the full CDS flanking 
sequences were cloned into pCR-BluntII-TOPO (Invitrogen) and transformed in one 
shot Top10 chemically competent E.coli. Several clones were verified with 
restriction analysis and DNA sequencing.  
 
3.3 Sequence alignments and phylogenetic analysis 
Phylogenetic analysis was performed based on multiple alignments of p38 MAPKs 
from different species; human (h), rat (r), mouse (m), Xenopus (x), zebrafish (z) and 
medaka fish (med). ENSEMBLE protein codes:  hp38α: ENSP00000229795 hp38β: 
ENSP00000333685 hp38γ: ENSP00000215659 hp38δ: ENSP00000211287 
mp38α:ENSMUSP00000004990 mp38β:ENSMUSP00000132439 
mp38γ:ENSMUSP00000086207 mp38δ: ENSMUSP00000004986 
rp38α:ENSRNOP00000000617 rp38β: ENSRNOP00000009325 rp38γ: 
ENSRNOP00000046455 rp38δ: ENSRNOP00000000621 xp38α: 
ENSXETP00000000926 xp38β: ENSXETP00000048165  xp38γ: 
ENSXETP00000048167 xp38δ: ENSXETP00000000923 medP38α.1: 
ENSORLP00000008135 medP38α.2: ENSORLP00000020176 medp38β: 
ENSORLP00000011217 medp38γ.1: ENSORLP00000020405 medp38γ.2 
ENSORLP00000011305 medp38δ: ENSORLP00000000486 zp38αA: 
ENSDARP00000040361 zp38γ: ENSDARP00000011298 zP38αb.1 
ENSDARP00000035686, zP38αb.2 ENSDARP00000040146 
 
RNA isolation and reverse transcriptase PCR 
Total RNA was extracted from embryos at different stages of development using 
Trizol reagent (Invitrogen) phenol-chloroform and phase-lock gel. RNA quality 
control was performed by agarose gel electrophoresis. Expression patterns during 
development of P38β and P38δ were determined by RT-PCR with SuperScript™ III 
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One-Step RT-PCR System with Platinum® Taq DNA polymerase (Invitrogen) and 
the full CDS-flanking primers used for cloning. β-actin was used as a control fw 5’ 
ggcacccagcacaatgaagat 3’ rv 5’ aagtcatagtccgcctagaagcat 3’.  
In situ hybridization  
Anti-sense digoxigenin labeled RNA probes were synthesized from the full length 
cDNA cloned in pCR-BluntII-TOPO. The constructs were linearized and antisense 
probes were synthesized using the DIG RNA Labeling Kit (Roche) and T7, sp6 RNA 
polymerase (Maxiscript kit, Ambion) according to the orientation of the gene in the 
TOPO construct. Zebrafish embryos were harvested at 24 and 48hpf, dechorionated 
and fixed overnight in 4% paraformaldehyde in PBS at 4°C. In situ hybridization was 
performed as described previously (Westerfield 200).  
 
 
Results & Discussion  
Cloning of zebrafish p38β and p38δ   
To obtain the cDNA of p38β and p38δ, gene specific primers were designed based 
on the ensemble predictions zgc:86905 and im:7136778 (Zv8), respectively (Table 
1). Several clones were sequenced for both p38β and p38δ. One single p38δ 
transcript was obtained of 1089bp encoding for a 362 amino acid (a.a.) protein with 
a 99.4% identical sequence to im: 7136778. Since there was only one transcript 
found, the splicing of p38δ RNA is most likely to occur uniformly. In contrast, three 
P38β transcripts were obtained of which two, with a size of 1086bp and 1087bp, are 
mostly identical. The full protein (361a.a) is translated from the 1086bp transcript. 
The second transcript contains a single nucleotide insertion that changes the 
reading frame and results in an early truncation of the protein. The third transcript of 
1263bp contains a retained intron of 170bp with an early stop codon, resulting in a 
truncated protein. The obtained clones were sequenced and the complete coding 
sequences of the newly identified transcripts p38β.2(1087bp) and p38β.3(1263bp) 
were submitted to GenBank: JQ513868 and JQ513869 respectively. 
 
Multiple sequence alignment of zebrafish P38 isoforms 
After the cloning of the zebrafish P38β and P38δ all isoforms were compared in a 
multiple sequence alignment (Fig1). Previously, the crystal structures of the human 
orthologues have been resolved and most functional domains are identified (Wilson 
et al.1996; Patel et al. 2009). Functional differences between the different P38 
isoforms have been assigned to specific amino acids. Comparison of the sequences 
to other species revealed that these domains and residues are preserved in the 
analogous positions in zebrafish P38 MAPKs. The comparison of the primary 
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structure between isoforms, the dual phosphorylation site, catalytic site and protein-
protein interaction sites are indicated in the alignment (Fig1).  
As observed in most kinases, the N-terminal and C-terminal regions of the protein 
are folded into two small lobes and the catalytic domain is situated at the interface 
of these two lobes (Fig1B). The dual phosphorylation motif (TXY) is located on the 
activation lip at the C-terminal lobe. The position of the activation lip changes upon 
phosphorylation and induces additional conformational changes of mostly hydrogen 
interactions between residues. The N’ and C’ lobe rotate 5º towards each other 
(P38α) aligning the catalytic residues in the hinge region, glycine-rich loop and α-
Helix C. The phenylalanine of the DFG motif, which sterically interferes with ATP 
binding in the non –phosporylated form, changes its position, thereby enabling the 
MAPK to become fully active (Zhang et al. 2011). 
The dual phosphorylation motif and DFG site are conserved between all zebrafish 
P38 isoforms and are located in a highly conserved region, as indicated by the use 
of a blue font color (Fig1A). The existing amino acid differences in the glycine-rich 
loop, hinge region and α-Helix C are often found between P38α/β and P38γ/δ 
isoforms. The catalytic site is more than 80% conserved between the P38α and 
Table 1. The zebrafish contains all isoforms of the P38 subfamily of MAPKs.  
We confirmed the presence of the first P38β transcript and identified novel alternative 
transcripts coding for truncated proteins. No additional transcripts of P38δ have been 
identified. P38αA and P38αB are duplicated genes found in zebrafish.  The linkage group 
corresponds with chromosome number, based on the Ensemble website.* Sequences 
submitted to Genbank: mapk11_2 JQ513868 and mapk11_3 JQ513869. **  Full coding 




P38β isoforms. SB203580 and SB202190 inhibitors target the catalytic site and are 
known to be selective for P38α/β this is likely to be similar in zebrafish. The 175th 
a.a (histidine in zP38α) is the only highly variable residue in the region of the 
catalytic and activation domains. However, a possible contribution of this particular 
residue to the conformation of the activation lip or to the kinase activity is not 
reported yet. The D177L substitution, two residues upstream, is found to increase 
the activity of all isoforms except P38δ (Diskin et al. 2007).  
The two allosteric docking sites, CD domain and ED site have been found to be 
important for binding of activators, inactivating phosphatases and substrates 
(Tanoue et al. 2001). In the folded structure these sites are in close proximity and 
are part of a hydrophobic docking groove that is recognised by motifs on interacting 
proteins. Both domains consist predominantly of acidic amino acids and are 
conserved in zebrafish P38 MAPKs.  
In mammals, two MEKK independent mechanisms are known to specifically activate 
P38α. P38α is capable of auto-activation upon binding with the TGF-β-activated 
protein kinase 1-binding protein 1 (TAB1) or after phosphorylation of Tyr323 by 
Zeta-chain-associated protein kinase 70 (ZAP-70), a kinase that is thought to occur 
specifically in antigen receptor stimulated lymphocytes and natural killer cells 
(Cuadrado, Nebreda, 2010). TAB1 interacts with several residues in the C-terminal 
domain inside as well as outside the allosteric docking sites (Ile117, Gln121, Thr219 
and Ile276 in zP38α) (Zhou et al. 2006). In zebrafish, TAB1 interacting residues are 
also conserved in P38α. In contrast, Tyr323 is replaced by phenylalanine in 
zebrafish P38αA, but is present in P38αB isoform and in other P38 isoforms. Tyr323 
is located in loop16 which spans both the C' lobe and the N' lobe. Recently 
identified activating mutations reveal the importance of this loop for the kinase 
activity since mutations of phe328 render all isoforms active, except P38δ (Diskin et 
al. 2007). The F325S substitution increases the activity of P38δ however this 
residue is not conserved in zebrafish.  
The least conserved protein region includes the MAPK insertion, α-Helix G and the 
L16 loop. The MAPK insertion (MKI), a feature characteristic for MAPKs and cyclin-
dependant kinase 2 (CDK2) related kinases, is located at the C'-lobe and consist of 
two perpendicular positioned α-helixes connected by a short loop. The function of 
the MKI domain is possibly involved in lipid binding (Diskin et al. 2008).  
P38β and P38δ expression during zebrafish development   
To determine the expression dynamics of p38β and p38δ genes through 
the course of zebrafish development, we performed semi-quantitative RT-PCR 







ubiquitously expressed from the zygote on, throughout zebrafish development and 
eventually in the adult zebrafish.  In contrast, p38δ is not maternally deposited and 
shows a dynamic expression pattern, as it increases at early blastula stage (16 
cells-sphere cells), decreases during gastrulation and early somitogenesis, and 
increases again until 48hpf, thereafter its expression becomes undetectable. The 
p38δ is expressed in the adult zebrafish.  
 
Expression of the two p38α genes and p38γ during the same developmental stages 
was reported previously (Krens et al. 2006a). The p38αA and p38γ have the same 






Figure 1. Multiple sequence alignment of zebrafish P38 isoforms. A) Amino acid 
sequence of zebrafish p38 MAPKs were aligned with CLC DNA Workbench 5.7.1. The color 
gradient marks the conservation: with red the most variable residue and blue highly conserved 
residues. Functional domains and motifs are boxed and important residues are indicated:  * 
catalytic residues, ^ TAB1 interaction site, + ZAP70 phosphorylation site ~ catalytic activity 
increasing mutation sites. The same functional domains and residues are displayed on the 
homology model of zebrafish P38α to illustrate the position in the folded protein (B). Highly 
variable residues are indicated (red). To obtain the zebrafish P38α folded protein structure 
homology modeling was performed with Swiss-Model on the web server of the Swiss institute 
of bioinformatics http://www.isb-sib.ch and based on the crystal structure of the human 
orthologue of inactive P38α (PDB 1R39). Molecular graphics image were produced using the 
UCSF Chimera package from the Resource for Biocomputing, Visualization, and Informatics 
at the University of California, San Francisco (supported by NIH P41 RR001081).  
 
 
Figure 2. RT-PCR of P38β and P38δ during zebrafish development. Gene specific 
primers were designed flanking the full coding sequences and used for RT-PCR analysis of 
p38β and p38δ expression from cleavage until hatching stages. RNA isolated from the 
zygote and adult tissue was used to determine possible maternal expression and 





Whole mount in situ hybridization of p38β and p38δ at 24hpf and 48hpf 
Whole mount in situ hybridization using antisense digoxigenin labeled RNA probes 
was performed to localize the expression of p38β (Fig 3) and p38δ (Fig 4) from 1 to 
5 dpf. At 1dpf p38β is highly expressed in the in the heart, lens, notochord and 
specific parts of the brain. In the forebrain p38β is expressed in the dorsal rostral 
cluster of the telencephalon and in the ventral diencephalon. furthermore the dorsal 
view of the 1dpf p38β in situ shows an concentrated expression at two 
perpendicular anatomical lines in the forebrain one on the left-right axis and second 
one, connected to the first, at the posterior side of the eyes on the left-right axis. 
Since from 16hpf the forebrain ventricle start to appear at this position p38β could 
be expressed and perhaps functional in the formation in the presumptive forebrain 
ventricle. Furthermore p38β is expressed in the midbrain tegmentum of the 
mesencephalon and although expressed in the entire the rhombencephalon a highly 
divined expression can be distinguished located at the position of the upper rhombic 
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lip. p38β continues to be expressed in the brain at 2,3,4 and 5 dpf. At 2dpf p38β 
expression is highest in the dorsal diencephalon, midbrain tegmentum and 
rhombencephalon.  At 3dpf an specific expression is detected in the mid-hindbrain 
boundary and also dorsal diencephalon. 4 days old zf embryos show p38β 
expression in the entire brain and heart and at 5dpf a high p38β expression is found 
in the iris of the embryo. 
 
Like most MAPK p38δ is also expressed predominantly in the brain of the 
developing zebrafish embryo. At 1dpf p38δ is expressed in the telencephalon and 
diencephalon of the forebrain and in the notochord. p38δ expression seems to 
concentrate more specifically in the telencephalon-diencephalon boundary and the 
mid-hindbrain boundary of the zebrafish brain at 2dpf. In addition, p38δ expression 
is also detected in the chondrocranium, pectoral fins and pharyngeal pouches. In 
the tail region p38δ is expressed in the somite boundaries which could possibly be 
the growing intersegmental veins which appear between 48- and 60 hpf. P38δ 
expression at the somite boundaries is also detected in 3dpf embryos.  furthermore, 
p38δ is expressed in 3dpf embryos in the dorsal diencephalon, midbrain 
tegmentum, rhombomeres of the hindbrain, chondrocranium, pharyngeal arches 
and pectoral fins. At 3dpf p38δ expression is detecteble in the developing gut and 
this expression will continue to be detected at 4- and 5dpf. At 4 and 5 dpf 
expression of p38δ in the rhombomeres of the hindbrain and the developed 
pharyngeal arches becomes more evident. 
 
Expression of the zebrafish p38α and p38γ isoforms have been described 
previously (Krens et al. 2006a). P38αA is expressed in the tegmentum, hindbrain, 
otic vesicle, pronephric duct and tail muscle at 24hpf and also in the brachial 
arches, cerebellum and gut at 48hpf. The p38γ is expressed in the brain at 24hpf 
and 48hpf. It also shows an expression at the somite boundaries at 24hpf.  
Figure 3. Whole mount in situ hybridisation showing p38β expression in wild-type 
zebrafish embryos. Presence of p38β RNA was detected in the brain, heart and lens.  
Antisense In situ probes of the full length coding sequences where used. 1dpf upper 
panel Lateral view anterior to left dorsal to top in situ images. p38β expression is 
detected in the heart(hrt),ventral diencephalon(vd) dorsal rostral cluster of the 
telencephalon(drc), midbrain tegmentum(mt), the notochord(nc) the upper rhombic lip(url) 
and the rest of the rhombencephalon(rb)/hindbrain. 1dpf lower panel left dorsal view 
anterior to left, p38β expression in the lens(l) 1dpf lower panel right anterior view dorsal 
to top, show also expression of p38β in the presumptive forebrain ventricle(fv). 2dpf left 
and middle image Lateral view anterior to left dorsal to top in situ 2dpf right image 
dorsal view anterior to left. Expression in the dorsal diencephalon(dd), midbrain 
tegmentum and rhombencephalon(rb)3,4,5dpf Lateral view anterior to left dorsal to top. 
p38β expression in the dorsal diencephalon and mid-hindbrain boundary(mhb) 3dpf, 




Figure 4. Whole mount in situ hybridisation showing p38δ expression in wild-type 
zebrafish embryos. 1dpf Lateral view anterior to left dorsal to top in situ image. expression in the 
telencephalon(te), diencephalon(de) and notochord(nc) 2dpf upper panel left Lateral view 
anterior to left dorsal to top in situ image. p38δ expression in the pharyngeal pouches(ph), 
telencephalon-diencephalon boundary (tdb), mid-hindbrain boundary(mhb), chondrocranium(cc) 
and pectoral fins (pf). 2dpf upper panel right Lateral view anterior to top enlargement of the 
anterior tail region is shown at the 2dpf lower panel right Lateral view anterior to left dorsal to 
top, expression at somite boundaries (sb). 2dpf lower panel middle image Lateral view anterior 
to left dorsal to top head and trunk region 2dpf lower panel left image dorsal view anterior to left, 
shows p38δ expression in the notochord(nc). 3dpf upper panel left and 3dpf lower panel left 
p38δ expression in the dorsal diencephalon(dd), midbrain tegmentum (mt), rhombomeres of the 
hindbrain (rb), chondrocranium, pharyngeal arches, pectoral fins and the developing gut. 3dpf 
upper panel right image of the middle of the tail showing expression of p38δ at the somite 
boundaries. 3dpf lower panel right expression in the habenulae(ha) of the diencephalon. 4dpf 
top and bottom image p38δ expression in the gut, pectoral fins, pharyngeal arches, dorsal 
diencephalon, midbrain tegmentum and rhombencephalon. 4dpf middle image dorsal view 
anterior to left showing high expression of p38δ in the dorsal diencephalon. 5dpf left and right 
image expression in the gut, pharyngeal arches, dorsal diencephalon, midbrain tegmentum and 
rhombomeres. 5dpf middle image p38δ expression strongest in the dorsal diencephalon and 





















Figure 5. Unrooted phylogenetic tree of the zebrafish to other vertebrates P38 
proteins. The phylogenetic tree was created with the ClustalW software from the DNA 
Data Bank of Japan(DDBJ) and the image was obtained  using Treeview 
(http://taxonomy.zoology.gla.ac.uk/rod/treeview.html). Amino acid sequences of full 
length sequence predictions (ENSEMBLE) and sequencing verified coding sequences 
were uploaded for multiple alignment  and subsequent neighbor joining analysis using 
default settings. The numbers indicate the occurrence of nodes during bootstrap 
analysis. The p-distance values are given of 1000 reiterations.  Human (h), rat, (r), 




Phylogenetic analysis of P38 MAPKs  
The unrooted phylogenetic tree based on the difference in amino acid sequences 
illustrates evolutionary conservation of the P38 MAPK isoforms between zebrafish, 
medaka, Xenopus, mice, rat and human(Fig5). The four zebrafish p38 isoforms 
cluster with their corresponding orthologues into separate branches. In addition, 
zebrafish and medaka are both teleost fish and the phylogenetic tree of P38 kinases 
shows their closely related origin since each isoform branch separates into three 
clusters of fish, mammalian and amphibian species.  
 
Like in mammals, zebrafish P38α and P38β are the most similar isoforms with 
~75% identity, and the catalytic domains share an even higher similarity (~80%). 
P38δ shows a slightly higher similarity to P38γ (61%) than when it is compared to 
the other isoforms: 60% with P38α and 57% P38β.  
 
Acknowledgments 
This project was financially supported by the European Community under the FP7 
ZF-Cancer project (HEALTH-F2-2008-201439). 
 
References 
1. Beardmore,V.A., Hinton,H.J., Eftychi,C., Apostolaki,M., Armaka,M., Darragh,J., 
McIlrath,J., Carr,J.M., Armit,L.J., Clacher,C., Malone,L., Kollias,G., Arthur,J.S., 2005. 
Generation and Characterization of P38beta (Mapk11) Gene-targeted Mice. Mol Cell 
Biol, 25,10454-64. 
 
2. Cuadrado,A., Nebreda,A.R., 2010. Mechanisms and functions of p38 MAPK 
signaling. Biochem. J, 429,403-417. 
 
3. Coulthard,L.R,. White,D.E,. Jones,D.L, McDermott,M.F,. Burchill,S.A., 2009. 
P38(MAPK): stress responses from molecular mechanisms to therapeutics. Trends 
Mol Med, 15(8),369-79 
 
4. Cuenda,A,. Rousseau,S,. 2007. P38 MAP-kinases pathway regulation, function and 
role in human diseases. Biochim Biophys Acta, 1773(8),1358-75. 
5. Chung,K.F., 2011. p38 mitogen-activated protein kinase pathways in asthma and 
COPD. Chest, 139(6),1470-9. 
 
6. Diskin,R., Lebendiker,M., Engelberg,D., Livnah,O., 2007. Structures of p38alpha 
active mutants reveal conformational changes in L16 loop that induce 
autophosphorylation and activation. J Mol Biol, 365(1),66-76.  
7. Diskin,R., Engelberg,D., Livnah,O.A,. 2008. Novel lipid binding site formed by the 




8. Eckert,R.L., Efimova,T., Balasubramanian,S., Crish,J.F., Bone,F., Dashti,S., 2003. 
p38 Mitogen-activated protein kinases on the body surface--a function for p38 delta. 
J Invest Dermatol, 120(5),823-8. 
 
9. Fearns,C., Kline,L., Gram,H., Di Padova,F., Zurini,M., Han,J., Ulevitch,RJ., 2000. 
Coordinate activation of endogenous p38alpha, beta, gamma, and delta by 
inflammatory stimuli. Leukoc Biol, 67(5),705-11. 
 
10. Fujii,R., Yamashita,S., Hibi,M., Hirano,T.,2000. Asymmetric p38 activation in 
zebrafish: its possible role in symmetric and synchronous cleavage. J Cell Biol. 
150(6),1335-48. 
 
11. Holloway, B.A., Gomez de la Torre Canny, S., Ye, Y., Slusarski, D.C., Freisinger, 
C.M., Dosch, R., Chou, M.M., Wagner, D.S., Mullins, M.C.,2009. A novel role for 
MAPKAPK2 in morphogenesis during zebrafish development.PLoS Genet. 
5(3),e1000413.  
 
12. Johnson,G.L., Lapadat,R., 2002. Mitogen-Activated Protein Kinase Pathways 
Mediated by Erk, Jnk, and P38 Protein Kinases. Science, 298,1911-12. 
 
13. Kim,E.K., Choi,E.J., 2010. Pathological Roles of Mapk Signaling Pathways in Human 
Diseases. Biochim Biophys Acta, 1802,396-405. 
 
14. Kalender,A., Selvaraj,A., Thomas,G., 2011. A matter of energy stress: p38β meets 
mTORC1. Cell Res, 21(6),859-61. 
 
15. Krens,S.F., He,S., Spaink,H.P., Snaar-Jagalska,B.E., 2006a. Characterization and 
Expression Patterns of the Mapk Family in Zebrafish. Gene Expr Patterns, 6,1019-
26. 
 
16. Krens,S.F., Spaink,H.P., Snaar-Jagalska, B.E.,2006b. Functions of the MAPK family 
in vertebrate-development.FEBS Lett. 580(21),4984-90.  
 
17. Kimmel,C.B., Ballard,W.W., Kimmel,S.R., Ullmann,B., Schilling,T.F., 1995. Stages of 
Embryonic Development of the Zebrafish. Dev Dyn, 203, 253-310. 
 
18. Lee,J.C., Laydon,J.T., McDonnell,P.C., Gallagher,T.F., Kumar,S., Green,D., 
McNulty,D., Blumenthal,M.J., Heys,J.R., LandvatterS.W., 1994. A Protein Kinase 
Involved in the Regulation of Inflammatory Cytokine Biosynthesis. Nature, 372,739-
46.  
 
19. Munoz,L., Ammit,A.J., 2010. Targeting p38 MAPK pathway for the treatment of 
Alzheimer's disease. Neuropharmacology, 58(3),561-8.  
20. Mudgett,J.S., Ding,J.,Guh-Siesel,L., Chartrain,N.A.,Yang,L., Gopal,S., Shen,M.M., 
2000. Essential Role for P38alpha Mitogen-Activated Protein Kinase in Placental 




21. Nebreda,A.R., Porras,A., 2000. P38 Map Kinases: Beyond the Stress Response. 
Trends Biochem Sci, 25,257-60. 
 
22. Pramanik,R., Qi,X., Borowicz,S., Choubey,D., Schultz,R.M., Han,J., Chen.G., 2003. 
P38 Isoforms Have Opposite Effects on Ap-1-Dependent Transcription through 
Regulation of C-Jun. The Determinant Roles of the Isoforms in the P38 Mapk Signal 
Specificity. J Biol Chem, 278,4831-9. 
 
23. Patel,S.B., Cameron,P.M., O'Keefe,S.J., Frantz-Wattley,B., Thompson,J., 
O'Neill,E.A., Tennis,T., Liu,L., Becker,J.W., Scapin,G., 2009. The three-dimensional 
structure of MAP kinase p38beta: different features of the ATP-binding site in 
p38beta compared with p38alpha. Acta Crystallogr D Biol Crystallogr, 65(Pt 8),777-
85.  
 
24. Roux,P.P., Blenis,J., 2004. Erk and P38 Mapk-Activated Protein Kinases: A Family of 
Protein Kinases with Diverse Biological Functions. Microbiol Mol Biol Rev, 68,320-44. 
 
25. Schindler,E.M., Hindes,A., Gribben,E.L., Burns,C.J., Yin,Y., Lin,M.H., Owen,R.J., 
Longmore,G.D., Kissling,G.E., Arthur,J.S., Efimova,T., 2009. p38delta Mitogen-
activated protein kinase is essential for skin tumor development in mice. Cancer Res, 
69(11),4648-55.  
 
26. Thornton,T.M., Rincon,M., 2009. Non-classical p38 map kinase functions: cell cycle 
checkpoints and survival. Int J Biol Sci, 5(1),44-51. 
 
27. Tanoue,T., Maeda,R., Adachi,M., Nishida,E.,2001. Identification of a docking groove 
on ERK and p38 MAP kinases that regulates the specificity of docking interactions. 
EMBO J, 20(3),466-79. 
 
28. Wang,X., Wu,H., Miller,AH., 2004. Interleukin 1alpha (IL-1alpha) induced activation 
of p38 mitogen-activated protein kinase inhibits glucocorticoid receptor function. Mol 
Psychiatry, 9(1),65-75. 
 
29. Wilson,K.P., Fitzgibbon,M.J., Caron,P.R., Griffith,J.P., Chen,W., McCaffrey,P.G., 
Chambers,S.P., Su,M.S., 1996. Crystal structure of p38 mitogen-activated protein 
kinase. J Biol Chem, 271(44),27696-700. 
 
30. Westerfield,M., 2000. The Zebrafish Book: A Guide for the Laboratory Use of 
Zebrafish (Brachydanio Rerio). ed. by 4th. 1 vols (Eugene, OR: Univ. of Oregon 
Press). 
31. Zarubin,T., Han,J., 2005. Activation and Signaling of the P38 Map Kinase Pathway.  




32. Zhou, X., Ferraris,J.D., Dmitrieva,N.I., Liu,Y., Burg,M.B., 2008. MKP-1 inhibits high 
NaCl-induced activation of p38 but does not inhibit the activation of TonEBP/OREBP: 
opposite roles of p38alpha and p38delta. Proc Natl Acad Sci U S A, 105(14),5620-5. 
 
33. Zhang,Y.Y., Wu,J.W., Wang,Z.X., 2011. Mitogen-activated protein kinase (MAPK) 
phosphatase 3-mediated cross-talk between MAPKs ERK2 and p38alpha J Biol 
Chem, 286(18),16150-62.  
 
34. Zhou,H., Zheng,M., Chen,J., Xie,C., Kolatkar,A.R., Zarubin,T., Ye,Z., Akella,R., 
Lin,S., Goldsmith,E.J., Han,J., 2006. Determinants that control the specific 













































































The P38αA and Erk2 are essential for epiboly 
initiation by regulating common and 
separate developmental genetic programs 
 

































The P38α and Erk2 MAPKs play an essential role in morphogenetic movements 
during zebrafish gastrulation, in particular during epiboly. Using time-lapse imaging 
we demonstrated that lethality of P38α and Erk2 morphants is correlated with 
defective cell migration of the blastomere margin, as a result dissociated blasoderm 
cells. Since knock-down of either of the two MAPKs causes similar severe 
morphological defects, or even arresting embryonic development before the onset 
of epiboly, we set out to investigate their putative functional redundancy in epiboly 
initiation. To identify distinct and overlapping roles for Erk2 and P38 at this early 
stage of developmental morhogenesis, we performed transcriptome analysis of 
high/oblong stage P38α and Erk2 knockdown embryos. 
We found common genes affected by both P38α and Erk2 knockdown and genes 
specifically affected by depletion of either P38α or Erk2. The common gene set and 
the Erk2 knock down specific gene set include transcripts regulating cell migration 
and adhesion properties associated with epiboly. Epithelial cell adhesion molecule 
(Epcam) and bloody fingers (Blf) expression is decreased by either P38α or Erk2 
morpholino treatment. The Aryl hydrocarbon receptor nuclear translocator 2 (Arnt2) 
is specifically up-regulated in P38α morphants. Apelin receptor b (Aplnrb), c-x-c 
chemokine receptor 4 (Cxcr4), snail2 (Snai2), ras homolog gene family member Ab 
(Rhoab) and fyn oncogene related to src (Fyna) are down-regulated by Erk2 
morpholino while interferon regulatory factor 6 (Irf6) is up-regulated. 
Interestingly, gene ontology analysis revealed a large pool of ribosomal proteins 
with low expression levels and several histone protein coding transcripts where 
significantly up-regulated by the P38α morpholino. Imbalanced histone and 
ribosomal protein expression levels are associated with loss of nuclear integrity. We 
found also that P38α morphants fail to induce expression of P53, a key cell cycle 
checkpoint regulator, upon DNA damage induced by camptothecin treatment. These 
results show that the function of P38α in stress signalling is already put to use 
during initial stages of embryogenesis. Additionally, we conclude that both P38α and 










Mitogen Activated Protein Kinase (MAPK) signalling is involved in divers cellular 
processes such as cell motility, cell cycle progression, survival, protein biogenesis, 
and differentiation. MAPK signalling cascades consist of an upstream MAPKKK 
(MEKK) which activates a MAPKK(MEK) to finally activate a MAPK by 
phosphorylation. There are 14 MAPK proteins, which are subdivided according to 
their dual-phosphorylation (activation) motif (T-X-Y) into the extracellular signal-
regulated kinases (Erk1,2,3,4,5,6,7), c-Jun amino (N)-terminal kinases (JNK1/2/3) 
and P38 isoforms (α,β,γ, and δ) [1-6].  
Erk2, Erk5, P38α and Jnk1/2 MAPK family members appear to be essential for 
vertebrate development as knock-out mice die within the first 12 days of 
development [7-9]. In zebrafish all 14 MAPK are conserved and previous research 
accomplishments have gained insight into the functions of ERK2, P38α and JNK1/2 
in the first stages of development.  
P38α is asymmetrically activated on one side of the blastodisc and regulates the 
first cell divisions during the early cleavage period. The side of P38α activity 
overlaps with the expressed dorsal-specific zygotic gene dharma/bozozok however 
dorsal-ventral axis formation is unaffected after injection with dominant negative 
P38α RNA suggesting that P38α is dispensable for this process [13]. In contrast, a 
clear function of JNK in dorsal-ventral patterning has been demonstrated with a MO 
knock-down approach which leads to ventralized embryos. JNK and MEKK4 are 
part of a dorsalization pathway that is induced by Axin/JNK and inhibited by Aida 
[14]. Furthermore, ERK2 and P38α are both found to be involved in epiboly 
movements during gastrulation: the spreading of embryonic cells of the blastoderm 
over surface of the yolk until fully covered and occurs from 4.3 hpf (dome stage) to 
10 hpf (tail bud). Prior to epiboly, the blastula surface cells differentiates into the 
enveloping layer (EVL), of which the forerunner cells delaminate (later forming the 
Kupples vesicles) and the yolk syncycial layer (YSL), both are the essential 
mediators of epiboly [15].   
Activated forms of ERK2 and P38α are detected at the margin of the blastoderm 
throughout all stages of epiboly. When the blastoderm cells reach the equator and 
cover the yolk cell by half, the cells at the margin are induced into mesendoderm 
cell fates by a combination of Nodal and Fgf signaling. [13,16]. Fgf morphogens 
specificallyare shown to activate downstream Erk1/2 signalling and are involved in 
the specification and maintenance of mesoderm cell faith by regulation of T box 
transcription factors [17-19]. Erk2 levels causes defects in convergent-extension 
movements, and a strong knock down of Erk2 leads to a full developmental arrest in 
blastula stage embryos [16]. In addition, the Erk2-MAPK pathway functions 
downstream of Fgf [16] and is a modulator in mesendoderm formation,, which is 
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apparent from reduced levels of expression of the mesodermal markers No tail, 
Tbx6 and Tbx16 in ERK2 depleted embryos [20]. The first evidence for a role of 
P38α mediated signaling in epiboly came from a large genetic screen for maternal-
effect mutants that display morphological defects at or after mid blastula transition 
(MBT) [21,22]. In this screen, the betty boop mutant (bbp) was identified as bbp 
mutant show strong epiboly defects characterized by a dramatic constriction of the 
blastoderm margin resulting in a yolk burst. The loss of function mutation in bbp was 
mapped in the Mitogen Activated Protein Kinase Activated Protein Kinase 2 
(Mapkapk2) gene, a specific substrate of P38 MAPKs. The same phenotype was 
observed by injection of dominant negative P38α RNA suggesting that this MAPK 
isoform plays a specific non-redundant role in regulating gastrulation cell 
movements [23].  
Since both P38α and Erk2 knockdown results in severe morphological defects the 
question remains what downstream target genes are regulated by the two MAPK 
that are essential for early embryogenesis. Erk2 and P38α were the first identified 
MAPKs, initially discovered as proteins which were rapidly phosphorylated after 
mitogen stimulation and osmotic shock respectively. Multiple cytosolic and nuclear 
substrates have been identified so far which was of great value for the molecular 
characterization of MAPK associated cellular events [24-29]. Although both MAPK 
are found essential for vertebrate development the molecular mechanisms are less 
well documented. MAPK are known to translocate to the nucleus and influence 
gene expression, after extracellular stimulation. In this study, we show that depletion 
of P38α zebrafish embryos fail to initiate epiboly, and thus phenocopies embryos 
that have been depleted from ERK2 by morpholino knockdown. We compare 
transcriptomes of these P38α and Erk knock down embryos at high/oblong stage, 
prior to epiboly initiation, to identify specific and common downstream target genes 
that are necessary for epiboly progression.     
 
Material & Methods  
Morpholino injections  
ABXTL embryos were injected between 0- and 1- cell stage with either P38αA 
translational blocking morpholino (ATG) 5’GTGGGTCTTTCTTTCTGCGACATGC3’, 
P38αA splice blocking morpholino 
(splice)5’AGCTGCATACACGAAATATGAAAGT3’, ERK2 translational blocking 
morpholino 5’CACCCAAAAGCACCAGGAAAAGCTC3’ or a standard control 
morpholino 5’CCTCTTACCTCAGTTACAATTTATA3’(Genetools). Morpholino’s 
where dissolved in 1XDanieau’s buffer [58mM NaCl, 0.7mM KCl, 0.4mM MgSO4, 
0.6mM Ca(NO3)2, 5.0mM HEPES pH7.6] containing 1% phenol red solution.   
Time Lapse Imaging  
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For a time course experiment of 16:40 hours embryos were dechorionated, placed 
on an agar coated willco dish and subsequently embedded in 1% low melting 
agarose and covered with eggwater. From 256 cell stage onwards, embryos where 
repeatedly imaged every 5 minutes with 10X magnification of the DIC microscope in 
a room temperature of 24°C. 200 pictures were processed in a movie of 28s with 
ImageJ software.   
Protein isolation & western blotting  
Embryos were dechorionated in 1X pronase solution (2 mg/ml Roche Applied 
Science) for 7 minutes and washed several times in 1X Danieau buffer. Total 
protein was isolated from batch embryos first by deyolking in Ca2+/Mg2+ free 
solution. Cells where collected at 500 RCF and washed twice, once in Ca2+/Mg2+ 
free solution and once in PBS, before final lysis (30min incubation and vortexing in 
lysis buffer 1M Tris-Hcl pH7,4, 0,5M EDTA, 1 tablet protease inhibitor, 0,1M 
Na3VO4, 0,5M NaF).  
 
For biochemical analysis, protein extract were diluted in SDS sample buffer red 
+DTT (cell signaling #7723), sonificated and heated for 10 min at 95°C. 1 μg of the 
proteins samples were separated in a SDS-polyacrylamide gel electrophoresis 
(PAGE) and transferred to nitrocellulose membrane (Schleicher & Schuell, Den 
Bosch, The Netherlands) by western blotting. The membranes were blocked in 5% 
w/v non-fat dry milk in Tris-Buffered Saline-Tween 20 (TBST). The blots were 
incubated with of P44/42 MAPK Kinase antibody (Cell Signaling #9102 1:1000), P38 
antibody (Santa Cruz Biotechnology C-20 1:1000), pan-actin (Cell Signaling #4968 
1:1000) or P53 antibody (mouse antibody, kind gift from Alyson W. MacInnes 1:1) in 
TBST with 3% BSA (Sigma) overnight at 4°C. Signal was detected using a 1:5000 
dilution of horseradish peroxidase (HRP)-conjugated anti-rabbit or anti-mouse 
antibodies and the enhanced chemiluminescence method (Amersham).  
 
RNA isolation & transcriptome analysis  
Morpholino injected embryos of high oblong stage where snap-freezed in liquid 
nitrogen (without dechorionation) and stored in -80°C until all samples were 
collected. For RNA isolation freezed embryos where homogenized with pestle or 
with a bullet blender after addition of 300µl Qiazol (Qiagen). 1/5 of chloroform was 
added to the homogenate, mixed and transferred to phase-lock gel heavy (5-Prime) 
containing Eppendorf tubes of 1.5ml. The RNA liquid phase (top transparent 
solution) was separated from the rest of the sample by 15min at 12000 g and 
purified with rneasy MinElute cleanup kit (Qiagen) according to manufacture 
protocol. RNA quality was checked with the Agilent 2100 bioanalyzer using 
eukaryote total RNA pico series II protocol. RNA samples were delivered to the 
microarray department University Amsterdam www.microarray.nl/ who performed a 
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two-color microarray-based gene expression analysis with treatment (P38αMO ATG 
or ERK2MO ATG injected embryos) labelled Cy3 hybridized against control 
(stCTRMO injected embryos) labelled Cy5 on an Agilent 180k chip. For analysis, 
data files (MAGE and JPEG files of each hybridized chip position) were imported 
into Rosetta Resolver 7.2 (Rosetta Inpharmatics LLC). Two biological replicate 
intensity profiles were combined using the default intensity experiment builder which 
is implemented in the Rosetta Resolver system. P38α morpholino against standard 
control morpholino (252823310001_3 and 252823310002_3), ERK2 morpholino 
against standard control morpholino (252823310001_4 and 252823310002_4)     
 
Q-PCR  
50ng of total RNA was used for a 20μl cDNA synthesis reaction with the iScript 
cDNA synthesis kit (Biorad). Q-PCR reactions were performed in a 25 μl volume 
comprised of 1 μl cDNA, 12.5 μl of 2× iQ SYBR Green Supermix (Bio-Rad) and 10 
pmol of each primer.  
 
 
Cycling parameters were 94°C for 3 min to activate the polymerase, followed by 40 
cycles of 94°C for 15 sec and 59°C for 45 sec. Fluorescence measurements were 
taken at the end of each cycle. Melting curve analysis was performed to verify that 
no primer dimers were amplified. All reactions were done in duplicate or triplicate. 
Data were normalized using the Genex macro provided by Bio-Rad. 
Camptothecin treatment  
Embryos were injected with, pronase dechorionated and washed with 1X Danieau 
buffer within 1hpf. At 8 cell stage (+/- 1hpf) embryos were transferred to agarose 
coated plates and treated with either 500nM CPT or DMSO for 8hours at 31°C. After 







Knock down of P38α causes blastula stage arrest and prevents epiboly initiation.   
To study the function of P38αA in the first stages of zebrafish development the 
expression was blocked, by injection of a translation blocking morpholino (MO1) in 
zygote stage embryos. Development of (injected) embryos was followed with time 
lapse imaging starting from 256cell stage (Fig1a). At 6hpf uninjected or control 
morpholino (stCTRMO) injected embryos progressed normally to shield stage. 
However, more than 80% of P38αA knockdown embryos arrested at blastula stage, 
and did not undergo epiboly resulting in embryonic lethality a few hours later. This 
phenotype was confirmed by a splice blocking morpholino (MO2) against P38αA 
(Fig1b). Depletion of P38αA appeared to be more efficient with the translational 
blocking morpholino when compared to the P38αA splice blocking morpholino, an 
effect that is most likely due to the abundant maternally contributed spliced P38αA 
mRNA, that has been demonstrated previously [34]. Since knock-down of Erk2 also 
resulted in epiboly arrest we questioned whether the phenotypes of both morphants 
were identical and performed the time course experiment as well with Erk2 
morphants. In uninjected wild type embryos epiboly started at 06:10 hpf (24°C) and 
the embryos remained viable and developed further until the time lapse 
measurement was terminated at 16:40 hpf. Embryos injected with P38α 
translational blocking morpholino (MO1) developed until 8:50 hpf when the animal 
pole started to show excessive movements in contrast to the not moving margin and 
eventually resulted in the burst of the yolk and death of the embryo. Two different 
phenotypes were distinguished among the Erk2 epiboly arrested morphants. The 
first phenotype was almost similar to the P38α morphants and embryos died by a 
yolk burst due to failed migration of marginal cells (Fig1a ERK2MO upper panel). 
However, the deep cells of the animal pole in the Erk2 morphant curled through 
excessive movements and partly dissociated from the enveloping layer (EVL). In 
addition, the animal pole of Erk2 morphant took on a dome shape which indicates 
epiboly initiation. The second Erk2 morphant phenotype was much more severe 
since embryos died at 7:00 hpf because the cells of the animal pole started to 
dissociate (Fig1a ERK2MO lower). Western blotting with anti-Erk1/2 and anti-P38 
antibodies confirmed that P38α morpholino1 injected embryos expressed lower 
levels of P38 protein compared to stCTR morpholino. Erk2 morphants contained 
reduced Erk1/2 levels, however they also contained reduced P38 levels, possibly 






















Fig1: Time lapse imaging of P38α and ERK2 morphants. P38α morphants, Erk2 
morphants and WT embryos are imaged every 5 minutes starting at 256 cell stage 
(3hpf). Time lapse was performed with DIC microscopy using Zeiss EC Plan-Neofluar 
10×/0.30 objective and extended for 16 hours and 40 minutes. A Fragment images of 
time lapse showing epiboly stage starting at 06:10hpf in WT embryos but not 
morpholino injected embryos. ERK2MO embryos died by a yolk burst (upper panel) 
or dissociation of the blastoderm (lower panel). B a minimum of 30 embryos for 
each condition was used for morpholino injections at 1-cell stage. Phenotypes were 
scored at 6hpf were WT embryos are developed to shield stage. Injections are 
performed with an ATG or a splice blocking morpholino against P38α, an Erk2 
morpholino and the standard control morpholino was used as a control. C Western 
blotting with anti-Erk2 and anti-P38α antibodies on protein samples from P38αMO 
(ATG) and ERK2MO injected embryos prepared at high/oblong stage.  
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Transcriptome comparison of high/oblong stage Erk2 and P38α knock-down 
embryos. 
To compare the effects of Erk2 and P38α knock-down in the first hours of zebrafish 
development, transcriptome analysis was performed of (injected) embryos from 
high/oblong stage using a custom designed 180k Agilent chip. With a threshold of a 
twofold change relative to control morpholino (stCTR) injected embryos, a total of 
454 up-regulated and 455 down-regulated genes were selected as a result of P38α 
knock down, whereas Erk2 morphants displayed 964 up-regulated and 418 down-
regulated genes  (Fig2a). The Erk2 morpholino and P38α morpholino common gene 
pool of 229 genes shows almost equal number of genes up-regulated (114) versus 
down-regulated (115). Finally, we selected 1153 and 680 genes that were 
specifically affected by either Erk2 or P38α knock down, respectively. The P38α 
morpholino specific target has an equal number of up-regulated (340) and down-
regulated (340) genes. However, from the Erk2 morpholino specific set of 1153 
genes the largest pool of 850 genes were up-regulated and the rest of 340 genes 
were down-regulated. The percentage gene frequency of different fold change 
Fig2: Erk2 and P38α knock-down transcriptome analysis at high/oblong stage. A 
Venn diagrams of the number of genes up- or down- regulated by Erk2 and P38α 
translational blocking morpholinos with absolute fold change of 2 and p-value<10
-5
. B 
Histogram of % frequency P38MO effected genes (y-axis) within a fold-change margin (x-
axis) and p-value<10
-5
. Numbers on bars represent absolute numbers of genes. 
Transcriptome analysis results of two independent experiments each with a pool of five 
embryos. C Histogram of ERK2MO transcriptome. 
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thresholds for both Erk2 and P38α knock-down were plotted. For both Erk2 and 
P38α knock-down significant sets of gene targets could be distinguished with fold 
change thresholds as high as 8 (Fig2 b and c). Interestingly, higher threshold 
settings resulted in more down-regulated gene expression levels than up-regulated 
for both Erk2 and P38α knock-down. 
 
To address the biological processes represented by the Erk2 and P38α knockdown 
transcriptomes, gene ontology enrichment analysis was performed with total up-
regulated and down-regulated gene sets (Fig3). 258 out of 455 P38α down-
regulated genes were assigned to the gene ontology classification (GO). For Erk2 
knock-down 218 out of 418 could be analyzed with GO enrichment analysis. 
Compared to the 180k Agilent chip both Erk2 and P38α down-regulated 
transcriptomes have overrepresentation of genes involved in processes of early 
development such as mesoderm/ectoderm development and pattern/system 
specification. Embryonic patterning is regulated by morphogens such as Fgf, Wnt 
and the Tgf-β family members Nodal and Bmp. We found various morphogen 
pathway components to be affected by Erk2 or P38α knock-down (Supplemental 




morphogens, and the same pathways are involved in regulating cell migration and 
adhesion properties of blastoderm cells during epiboly. We found also genes 
directly involved in cell adhesion to be overrepresented in both Erk2 and P38α 
down-regulated gene pools. Different from Erk2 morpholino, the P38αMO1 down-
regulated gene pool contained overrepresentation of genes involved in protein 
Fig3: Biological processes enriched in Erk2 and P38α knock-down transcriptome data.  
A Bar graph of significantly enriched PANTHER™ GO slim biological processes compared to 
180k Agilent array using upregulated gene sets of P38α morphants in red (239/454) and Erk2 
morphants in green (569/964). B Bar graph of significantly enriched biological processes using 
downregulated gene sets of P38α morphants in red (258 of 455) and Erk2 morphants in green 
(218 of 418). * are significant overrepresented in Erk2 morphants and red * significantly 
overrepresented in P38α morphants. Comparison is made of %genes of the GO category in 
gene list of experimental condition compared to the %genes of the category in the 180k 
Agilent chip. Gene ontology enrichment analysis was performed with Panther software 
www.pantherdb.org using statistical overrepresentation function without Bonferroni correction. 
Only significant overrepresented biological processes in Erk2 or P38α morphant are shown 
with p-value ≤ 0.05 calculated with binominal statistics.      
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translation, cytokinesis, angiogenesis and muscle contraction. Erk2 knockdown 
resulted in the down-regulation of a large set of genes involved in transcription, 
predominantly transcription factors, and cell signaling cascades including the MAPK 
pathway. 
239 (of 340) P38α morpholino1 up-regulated and 569 (of 850) Erk2 morpholino up-
regulated genes were found by GO classification and enrichment analysis showed 
again overrepresentation of developmental genes (Fig3). Many P38α morpholino 
up-regulated genes seem to be involved in pattern specification and system 
development while the genes assigned to the mesoderm differentiation ontology 
were up-regulated (as well as down-regulated) by Erk2 morpholino.  
 
Identification of common and P38α, Erk2  specific gene targets involved in cell 
migration and adhesion  
Combined Transcriptome profiling and gene ontology analysis of epiboly arrested 
P38α and Erk2 knock-down embryos revealed drastic deregulation of genes 
regulating cell migration and adhesion underlying (supplemental Table 5). 
Interestingly, also a number tissue specific genes expressed in the EVL, YSL or 
margin were down- 
 
regulated either in both Erk2 and P38α morphants or specifically in Erk2 morphants. 
Erk2 and P38α morpholinos both down-regulated keratin 4 (Krt4), bloody fingers 
(Blf), epithelial cell adhesion molecule (Epcam), neuron navigator 3 (Nav3), and up-
regulated echinoderm microtubule associated protein like 3 (Eml3) and junction 
plakoglobin (Jup). Epcam, and Blf are known regulators of epiboly cell movements 
in zebrafish [35,36]. Transcriptome data suggested that keratin 18 is specifically 
down-regulated by Erk2 morpholino, however keratin 4 as well as keratin 8 
appeared to be dramatically down-regulated by Erk2 as well as P38α morpholino 
when validated with Q-pcr (Fig4a). Down-regulation of Nav3, zgc136359 and Ctsh 
by P38α and Erk2 knock-down was also confirmed with quantitative rtPCR. In 
addition transcriptome data suggest that the aryl hydrocarbon receptor nuclear 
translocator 2 (Arnt2) is specifically up-regulated in P38α morphants which is known 
to regulate cell-cell adhesion during gastrulation [37]. Six previously identified 
epiboly critical regulators were present in the Erk2 morpholino transcriptome 
including apelin receptor b (Aplnrb), c-x-c chemokine receptor 4 (Cxcr4), snail2 
(Snai2), ras homolog gene family member ab (Rhoab) and fyn oncogene related to 
src (Fyna) (down-regulated) and interferon regulatory factor 6 (Irf6) (up-regulated) 
[38-43]. Dlc, Cxcr4a, Aplnrb and Rpsa were indeed specifically down-regulated by 
Erk2 morpholino as validated with Q-pcr (Fig4b). Down-regulation of two P38α 
morphoplino specific cell adhesion regulating genes Map7d1/Zgc;172238 and 







P38α induces expression of ribosomal proteins, inhibits expression of histone 
proteins and maintains P53 protein levels after DNA damage in the gastrulating 
embryo. 
The transcriptome data of P38α knock down embryos from high/oblong stage 
includes a significant number of down-regulated genes with a function in biological 
protein synthesis. The majority of the genes listed in supplemental Table 6 are 
ribosomal proteins of which Rps8, Rpl13, Rpl19 and Rpl35 are known to have a 
function in nuclear stress signaling when not assembled into the ribosome [44,45]. 
Ribosomal proteins maintain cellular homeostasis most likely by inducing levels of 
P53 through binding to the P53-inhibitor MDM2 during stress. In zebrafish, Rps8, 
Rpl13, Rpl19 or Rpl35 recessive mutations are associated with growth impairment 
and tumor predisposition in zebrafish [46,47]. We identified several cancer 
associated ribosomal proteins downstream of P38α with transcriptome analysis 
followed by Q-pcr of morpholino knock-down embryos (Fig5a). In addition, we found 
a significant pool of histone protein genes being highly up-regulated. For example 
histone 3.2 was 16 fold higher expressed in P38α knock-down embryos 
(supplemental Table 7). Histone protein levels are tightly controlled during cell 
Fig4: Quantitative PCR of Erk2MO downregulated genes, P38αMO downregulated 
genes and common regulated genes. Graph depicts fold changes relative to 
stCTRMO. Results are confirmed with a second independent experiment.  
83 
 
cycle progression since elevated histone protein levels is essential for proliferation 
however an excess can cause  
genomic instability in the form of excessive chromosome loss, enhanced sensitivity 
to DNA damaging agents and cytotoxicity [48,49]. Furthermore, P38α and P53 are 
both stress induced proteins and functional in the same DNA-damage induced 
stress signaling pathway since P38α directly phosphorylates and activates P53 at 
Ser33 and Ser46 residues[50]. Interestingly in this report we were able to detect 
ribosomal protein down-regulation and histone protein up-regulation, stress 
associated cellular events, by knock-down of basal levels of P38α. Since we 
obtained these results from an early embryonic stage, were the presence of the P53 
protein is questionable, we investigated the presence of P53 protein with western 
Fig5: P38α regulates expression of ribosomal proteins and maintains P53 protein levels 
after DNA damage during early zebrafish development. A Graph of quantitative real time 
PCR results with rps8, rpl13, rpl19 and rpl35 fold changes in Erk2 and P38 morphants 
compared to stCTR morpholino injected. Results are confirmed twice with independant 
biological experiments B Western blotting with ant-P53 and anti-actin antibody on protein 
samples from P38αMO1 or stCTRMO injected embryos treated for 7hours with either 




blotting.  We used an anti-P53 antibody in the gastrulating embryo with and without 
the DNA damage inducing agent camptothecin (CPT) (Fig5b). P53 was indeed 
undetectable at 8 hpf after 7 hour treatment with DMSO, however, the level was 
induced by CPT in stCTRMO injected embryos. Importantly, P53 induction by CPT 
was reduced in P38α morphants suggesting the function of P38 in regulation of P53 
protein stability during stress.   
 
Discussion  
The P38α and ERK2 MAPKs are crucial factors that regulate the first stages of 
vertebrate development. Knock down of either of the two MAPKs arrests embryonic 
development in zebrafish before the onset of epiboly. We performed transcriptome 
analysis of high/oblong stage P38α and ERK2 knockdown embryos to identify 
distinct and overlapping roles for Erk2 and P38α at this early stage of development. 
Our results are in line of previous studies published by Holloway et al., who 
discovered a role for P38α in regulation of the marginal actin ring constriction in 
embryos undergoing epiboly by injecting dominant negative P38α RNA [23]. 
Additionally, morpholino knockdown of P38α totally abolished initiation of epiboly in 
this study. Time-lapse imaging revealed that P38α morpholino inhibits migration of 
marginal cells of the blastula at a stage before 50% epiboly when the F-actin ring is 
normally established [51]. Previously we reported the indispensability of ERK2 for 
zebrafish epiboly. In this study, we elaborate on these findings by directly comparing 
the knock-down phenotypes of P38α and ERK2, using time-lapse imaging and 
transcriptome profiling. Live imaging showed that either Erk2 or P38α knock-down 
induced epiboly arrest due to failed migration of marginal cells. In contrast, the deep 
cells remained to increase in motility and protruding forces against EVL and margin 
resulting in lethality of embryo (see movie4 ERK2MO). The Erk2 morpholino is more 
potent to block epiboly, than the P38α morpholino, and injection can result in failure 
of EVL to maintain embryonic cell integrity and finally lead to total dissociation of the 
blastoderm. Therefore knock-down of either Erk2 or P38α results in failed epiboly 
initiation, however the phenotypes are not completely identical. In addition, western 
blot analysis showed lower level of Erk2 and P38α protein in Erk2 morpholino 
treated embryos what can account for more severe but not completely Erk2 specific 
phenotype of these morphants. However, it is also possible that ERK knock-down 
indirectly effects P38 levels.  
Specific gene pools for Erk2 and P38α depleted embryos are found, which are at 
least three times larger than the common pool which is similarly affected by Erk2 
and P38α knock-down. A number of genes that can be associated with cell 
migration are found in the common pool (supplemental Table 5) of which Blf and 
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Epcam are previously found to be essential for a proper progression of epiboly 
movements[35,36]. Keratin 18 is down-regulated specifically by Erk2 according to 
the transcriptome analysis, however with Q-pcr we found that the expression of this 
gene is also down-regulated by P38α morpholino, but less drastically. Keratin 4 and 
keratin 18 are intermediate filaments that are part of the cytoskeleton of the EVL 
[52]. Down-regulation of these EVL markers suggest that the EVL does not 
differentiate properly. As a consequence the blastoderm of Erk2 morphants 
dissociates, most likely through impaired cytoskeleton of the EVL and loss of cell 
adhesion. Within the Erk2 morpholino specific gene pool we found additional epiboly 
related genes such as Aplnrb, Cxcr4, Snail2, Rhoab, Fyna and Irf6. The p38α 
specific down-regulated gene set contains a pool of adhesion and cell migration 
functional genes, however only one that was previously found to be essential for 
epiboly. Arnt2 knock-down caused mild defects of the blastoderm during epiboly 
and we found it to be up-regulated in P38α morphants. Some P38α targets are 
conserved in mammals, also humans, of which the function is still largely 
unresolved. These targets such as si:dkey-30c15.12, a cadherin domain containing 
protein, and Map7d1, a microtubule association domain containing protein, are 
interesting candidates for further expression and functional studies in zebrafish. 
Functional studies of the adhesion regulating molecule 1 (Adrm1) have also not yet 
been performed in zebrafish. However in vitro studies have shown that adrm1 is a 
functional ubiquitin receptor of the proteasome complex, is inducible by interferon-γ 
and increases adhesion to endothelial cells when overexpressed in macrophages 
[53,54]. Therefore genes such as Adrm1 and Map7d1 can be studied further, with 
morpholino knock-down, to investigate involvement in epiboly cell movements. 
Theoretically it is possible that P38α exerts its function in zebrafish epiboly primarily 
by regulating cytosolic proteins rather than controlling gene expression. In smooth 
muscle and endothelial cells the P38 substrate Mapkapk2 regulates activity of heat 
shock protein 27 (Hsp27) an F-actin polymerization modulator [55,56].   
Gene ontology analysis of P38α morpholino down-regulated gene set revealed 
specific enrichment of genes characterized with the GO-term ‘protein translation’. 
The protein translation gene ontology category consists of genes predominantly 
coding for ribosomal proteins (RP). A possible link of P38α and RP gene expression 
can be found in P53 regulation during stress signaling. Both RP and P38α have a 
positive effect on P53 stability and are perhaps involved in a similar mechanism 
where stress induced P38α activity maintains RP excess [57]. RP are in excess 
when they exceed rRNA levels and cannot be assembled into the 40s or 60s 
ribosome subunits. Unbound RP have the capacity to bind Mdm2 which, in absence 
of stress, binds and targets P53 to the proteasome complex for degradation [44].  
In line with this hypothesis, a second mechanism appeared from the transcriptome 
data involving suppression of histone proteins by P38α. This suggests that P38α 
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exerts its function in the cell cycle not only by controlling checkpoints, through P53 
and RP, but also cell cycle progression by regulating expression of histone proteins. 
Interestingly, our transcriptome analysis reveals that the neuroepithelial cell 
transforming gene 1(net1) is 25 fold down-regulated in Erk2 morphants. Net1 binds 
RNA polymerase 1 directly and stimulates the synthesis of rRNA in yeast [58]. 
Therefore, Erk2 and P38α MAPK activities may form a mechanism to maintain 
cellular homeostasis by having opposing roles in controlling the ribosome assembly 
and this mechanism is established already in the first stages of development.  
We have not detected P53 protein in DMSO treated stCTR morpholino injected 
embryos of 8hpf. Furthermore, P53 was drastically induced during initial stages of 
epiboly with the DNA damage, causing agent CPT in stCTR morpholino injected 
embryos but not in P38α morphants. These results suggest that P38α regulates P53 
stability and stress associated ribosomal protein expression in the zebrafish 
embryo. Further study investigating the association between P38α activity, P53 
stability, ribosomal protein expression and histone protein expression would be 
valuable to gain more understanding about the role of P38α in tumor formation.  
 
Conclusion  
Depletion of P38α prevents epiboly initiation and blocks further development of the 
embryo. With the help of transcriptome profiling, we found that the expression of 
multiple cell migration and adhesion functional genes to be disregulated, along with 
components of Nodal, Fgf, Wnt and Bmp morphogen pathways, which have a 
critical role ininterplay to regulate migratory properties of embryonic cells for 
developmental patterning. Many of these P38α target genes are also affected by 
Erk2 morpholino despite the fact that much larger gene sets do not overlap between 
the two conditions. Interestingly, P38α knock-down results in down-regulation of a 
large pool of ribosomal proteins while Erk2 Morpholino specifically down-regulates 
net1 a protein also involved in ribosome biogenesis. These results suggest that, in 
zebrafish, both ERK2 and P38α are crucial for epiboly initiation, but despite similar 
phenotypic outcomes have separate roles in transcriptional regulation. This is 
illustrated by the involvement of both ERK2 and p38 in maintenance of cellular 
homeostasis during early zebrafish development, however by playing seemingly 
opposing roles in ribosome biogenesis.     
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Identification of P38α target genes involved 
in the physiological angiogenesis 
































Developmental angiogenesis is one of the physiological processes were P38α 
MAPK signalling is found to be crucial. The formation of intersegmental blood 
vessels (ISVs) in the zebrafish embryos serves as a paradigm to study 
angiogenesis in vivo. Here we investigated the role of P38α in the embryonic 
angiogenesis and further focussed on the identification of the target genes.   
To study the role of P38α in angiogenesis we performed knock-down experiments 
with gene specific morpholinos. Unsaturated knock-down of P38α in zebrafish 
resulted in a delayed formation of intersegmental vessels and expansion of the 
intermediate cell mass. Scanning confocal microscopy of Tg(fli:EGFP) embryos 
revealed absence of filopodia on the tip cells of growing ISV indicating defective 
endothelial cell migration in P38α morphants. The P38 morpholino phenotype with 
defective angiogenesis was confirmed by the P38 inhibitor BIRB796. When applied 
at the 4-8 somite stage the inhibitor completely blocked sprouting of the ISV. To 
identify P38α target genes involved in physiological angiogenesis we compared the 
P38α knock-down transcriptome with the GFP+ enriched gene set of Tg(fli:EGFP). 
T-cell activation RhoGTPase activating protein b (Tagapb) was affected by P38α 
morpholino and among the pool of GFP+ enriched genes. The vascular endothelial 
zinc finger 1a (Vezf1) affected by P38 morpholino, was not specifically expressed in 
the vasculature however was reported previously to play a role in angiogenesis.  
Furthermore the runt-related transcription factor 1 (Runx)  transcription factor was 
upregulated in P38 morphants which plays an important role in definitive 














The virulence component of anthrax lethal toxin lethal factor (LF) is an zinc-
metalloprotease that cleaves the NH(2) termini of mitogen-activated protein kinase 
kinase 1 and 6 (Mekk) causing severe vascular damage.[1,2] This association of 
MAPK with vascular morphogenesis is further supported by numerous in vitro and in 
vivo studies which lead to the overall conclusion that Erk2, Erk5 and P38α MAPK 
are separately indispensible for angiogenesis: the branching of vasculature from 
preexisting blood vessels. In contrast, MAPK have not been reported to be involved 
in vasculogenesis: the formation of blood vessels from endothelial cell precursors 
(angioblasts). P38α is in particular involved in regulation of cell migration and 
permeability of endothelial cells[3]. Targeted P38α deletion causes placental 
angiogenesis defects and subsequent cardiovascular defects in the embryo 
resulting in lethality starting at E10.5.[4,5]      
The P38α MAPK, and the other isoforms β, δ, γ of the P38 MAPK subfamily, are 
also known as stress activated protein kinases since activity is induced by stressors 
such endotoxins, hypoxia, cytokines, DNA damaging factors etc.[6] However P38α 
activity can be stimulated by growth factors and besides a role in stress signaling is 
also involved in physiological and developmental processes[7]. P38α and P38β, 
show a wide tissue expression and can be activated by Mek3 and Mek6 which are 
in turn activated by an Mapkkk (Mekk) [7-10]. Multiple Mekks are identified to 
function in the Mekk-Mek3/6-P38α/β cascade[11]. Mekk3, functional in both the 
P38α as Mek5-Erk5 cascade, was identified as an essential gene for vascular 
morphogenesis. Knock-out of Mekk3 in mice is lethal, starting at E11, due to 
extensive defects in blood vessel formation in the embryo, placenta and yolk sac 
[12]. 
Several In vitro studies have contributed to identification of the molecular signaling 
events of angiogenesis depending on  P38α. P38α activation is triggered by the 
angio-proliferative factors as vascular endothelial growth factor (Vegf) or fibroblast 
growth factor 2 (Fgf2) which regulate different aspects of angiogenesis: endothelial 
tip cell sprouting, proliferation, lining, migration and tube formation. P38α regulates 
the expression of Vegf post transcriptionally by increasing mRNA half-life and is 
functional downstream of Vegf in endothelial cells as well [13]. Phosphorylation of 
the Tyrosine-1214 residue of Vegfr2 (kdrl, flk1), through ligand binding, leads to 
activation of P38α and subsequent Mapk activated protein kinase 2 (Mk2)-Hsp27 to 
drive actin remodeling in stress fibers [14,14-16]. Furthermore, Nck, Fyn, Pak2 and 
Cdc42 are found to function upstream of P38α when stimulated by Vegfr2 [17]. 
Alternatively, Raftk/Pyk2 and Src have been reported to increase P38α activity and 
regulate migration of endothelial cells in response to Vegf[18]. A negative feedback 
signal has also been reported. Vegfr2 induces expression of MiR-20a which blocks 
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expression of Mekk3 mRNA leading to decreased P38α activity and eventually 
inhibition of endothelial cell migration[19].  The Vegf-A bound Vegfr2 stimulates 
P38α activation when complexed with the co-receptor Neuropillin-1 (Nrp1) leading 
to vessel branching in subcutaneous matrigel plugs.  Excessive vessel branching in 
matrigel plugs was observed after stimulation with Vegf-A165 a splice variant that 
complexes Vegfr2 with both coreceptors Nrp1 and heparin sulphate proteoglycan 
(Hspg) also leading to P38α activition[20].  Vegf-A165 induced endothelial cell 
organization and pericyte association was disturbed in subcutaneous matrigel plugs 
treated with the P38 inhibitor SB203580.  
On the contrary, P38 stimulated with Fgf2 in endothelial cells has been suggested to 
have a negative effect on angiogenesis. Fgf2 caused a sustained P38 activity in 
vascular endothelial cells in vivo in the chick chorioallantoic membrane and 
inhibition with the P38 inhibitor SB202190 enhances neovascularisation. Based on 
this experiment Fgf2 stimulated P38 is suggested to inhibit endothelial cell survival, 
proliferation and differentiation in collagen gel cultures of bovine capillary 
endothelial cells [21].  
Furthermore, P38 is likely to be involved in inflammation linked angiogenesis 
mediated by Interleukin 1β[22]. Endothelial tube formation and migration induced by 
Interleukin 1β was depending on Traf6 complex formation with caveolin-1 and 
subsequent P38-MK2 activation. TRAF6 activation of P38-Mapk is could have been 
mediated via the transforming growth factor (Tgf)-β-activated kinase 1 (Tak1)/Tak1-
binding protein 1 (Tab1)/Tab2 signaling complex [23].  
Targeted knock-out studies in mice have clearly demonstrated that the P38α is 
essential for angiogenesis and could not be compensated by the other P38 
isoforms. Most studies of P38α dependant angiogenesis, tough mostly performed in 
vitro using non-selective P38 inhibitors, have identifyed some of the molecular 
events upstream of P38. Since P38α is able to affect the activity of many substrates 
including transcription factors the downstream signalling and gene expression 
during angiogenesis is still an unexplored area. At 1 day post fertilization the 
zebrafish forms the intersegmental vessels (ISV) allowing study of angiogenesis 
that can be visualized in detail. The growth of ISV along the somite boundaries is 
often assayed as measure for physiological angiogenesis. Since we have recently 
developed P38α specific antisense oligonucleotides (morpholinos) to knock-down 






Material & Methods  
Zebrafish husbandry 
Zebrafish (Danio rerio) wild type line was maintained under standard conditions and 
guidelines given in the zebrafish book (Westerfield 200). Embryos were kept at 
28°C or 31°C to adjust required speed of development for experiment.  
 
Morpholino microinjection and life imaging  
Tg(fli:EGFP)y1 (Lawson et al., 2002) embryos were injected between 0- and 1- cell 
stage with either P38αA translational blocking morpholino (ATG) 
5’GTGGGTCTTTCTTTCTGCGACATGC3’, or standard control morpholino 
5’CCTCTTACCTCAGTTACAATTTATA3’(Genetools). Morpholino’s where dissolved 
in 1XDanieau’s buffer [58mM NaCl, 0.7mM KCl, 0.4mM MgSO4, 0.6mM Ca(NO3)2, 
5.0mM HEPES pH7.6] containing 1% phenol red solution.  Injected embryos were 
kept at 28°C for live imaging.  
 
Chemical Inhibitor treatment of Tg(fli1:egfp)y1 
The Pan-P38 inhibitor Birb-796 was dissolved in DMSO and used to block P38 
activity in Tg(fli:EGFP)y1 embryos. Because the inhibitor cannot pass through the 
chorion sufficiently, embryos have been mechanically dechorionated in Danieau 
buffer into agarose coated dishes. 100 μM Birb796 was added at 4-7 somite stage 
before sprouting of ISVs (around 24somite stage). Embryos were kept at 28°C and 
staged in hours post fertilization (hpf) according to (Kimmel et al. 1995) for live 
imaging.  
 
Protease dissociation of Tg(fli1:egfp)y1 and FACS 
GFP+ cells were isolated from untreated Tg(fli:EGFP)y1 of 24hpf kept o/n at 28°C or 
31°C.  Embryos have been bleached and dechorionated prior to deyolking and 
dissociation. Dechorionation was performed by enzymatic digestion with Pronase (2 
mg/ml Roche Applied Science) for 7 mintutes with subsequent washing in 
1XDanieau’s buffer. Dissociation was performed as previously reported (Covassin 
et al. 2006).   On average 220 embryos per condition was sufficient for 1x107 cells 
which on average would be sufficient for 1.4 μg of GFP+ RNA. Dissociated cells 
were centrifuged for 5 min at 500 RCF and resuspended in Leibovitz medium L15 
without phenol red, 1% fetal calf serum, 0.8 mM CaCl2, penicillin 50 U/mL and 
streptomycin 0.05 mg/mL. The cell suspension was filtered through a 50 µm 
CellTrics filter (Partec) for FACS (BD FACS AriaII cell sorter using a 70-100 µm 
nozzle). sorted GFP+ and GFP- cells were collected in 1/3 volume L15, 0.8 mM 
CaCl2, 10% fetal calf serum, 10% zebrafish embryo extract, penicillin 50 U/mL and 
streptomycin 0.05 mg/mL. Cells were immediately collected and lysed in QIAzol 
reagent for RNA isolation. On average 200 embryos per condition was sufficient for 
1x107 GFP+ cells for a yield of 1.4 μg of RNA.  
105 
 
RNA isolation for q-PCR or transcriptome analysis  
1/5 of chloroform was added to the Qiazol cell lysis, mixed and transferred to phase-
lock gel heavy (5-Prime) containing eppendorf tubes of 1.5ml. The RNA liquid phase 
(top transparent solution) was separated from the rest of the sample by 15min at 
12000 g and purified with rneasy minelute cleanup kit (Qiagen) according to 
manufacture protocol.  
50ng of RNA was used for cDNA synthesis for qPCR expression analysis of fli and 
flt4 (primers Covassin et al.2006) relative to 18S rRNA (primers Tang et al. 
2007).RNA samples were delivered to the microarray department University 
Amsterdam www.microarray.nl/ who performed a RNA quality check with the Agilent 
2100 bioanalyzer using eukaryote total RNA pico series II protocol.  
A two-color microarray-based gene expression analysis with treatment (GFP+) 
labelled Cy3 hybridized against control (GFP-) labelled Cy5 on an Agilent 180k chip. 
For analysis, data files (MAGE and JPEG files of each hybridized chip position) 
were imported into Rosetta Resolver 7.2 (Rosetta Inpharmatics LLC). Three 
biological replicate intensity profiles were combined using the default intensity 
experiment builder which is implemented in the Rosetta Resolver system.  28˚C 
GFP+ against GFP- (252823310038_2, 252823310039_4, 252823310040_2) and 
31˚C GFP+ against GFP- (252823310038_3, 252823310039_1, 252823310040_4). 
0.1pmol P38α morpholino or standard control morpholino was injected in zebrafish 
embryos and RNA was isolated at 24hpf (31˚C). RNA samples were used for 
transcriptome analysis with a common reference design (common reference=pool of 
all P38α morpholino and standard control samples) A two-color microarray-based 
gene expression analysis with treatment (P38α morpholino or standard control 
morpholino) labelled Cy5 hybridized against control (common reference) labelled 
Cy3 on an Agilent 180k chip. Three biological replicate intensity profiles were 
combined using the default intensity experiment builder P38α morpholino against 
common reference (P38α morpholino against common reference 252823310118_1, 
252823310118_3, 252823310119_1), (standard control morpholino against 
















P38α regulates growth of ISV and is essential for zebrafish angiogenesis  
P38αA is widely expressed in the most tissues and has an early developmental 
function in epiboly. Saturated knock-down with gene specific translational blocking 
morpholinos causes severe morphological abnormalities and lethality (chapter IV). 
Therefore we studied the role of P38α in embryonic angiogenesis under unsaturated 
knock-down conditions. We performed a titration experiment in Tg(fli:EGFP) with 
our previously designed morpholino to obtain the pool of embryos displaying 
vascular defects and minor morphological defects for further analysis. In the wild 
type embryos the intersegmental vessels (ISV) in the trunk arise from the lateral 
posterior mesoderm (LPM), and migrate to the dorsal aorta. From the dorsal aorta 
the ISV grow along the vertical somite boundaries dorsally at 20 somite stage. 
Reaching the dorsal most portion of the trunk the ISV form a T shape. Tips of 
neighbouring vessels connect into the dorsal longitudinal anastomotic vessels 
(DLAV) which runs horizontally. Unsaturated knock-down of P38α resulted in a 
significant delayed growth of ISV Fig1a. 
Fig1. Unsaturated morpholino knock-down of P38α delays development of ISV. A: 
Transmission and florescent stereo images of 1,5dpf (28˚C) Tg(Fli:eGFP) embryos injected 
with P38α or standard control morpholino. B: Optimization of unsaturated knock-down to 
obtain the pool of embryos displaying vascular defects and minor morphological defects. C: 
Confocal images showing ISV of Tg(Fli:eGFP) embryos injected with standard control 
morpholino left or P38α morpholino right 20X magnification: upper panel. Endothelial cells of 
P38α morphants display an aberrant morphology (more packed and less stretched). 1,5dpf 
P38α morphs have sprouted ISV that lack filopodia: middle panel. Formation of DLAV is 










Fig2. The P38 inhibitor Birb798 blocks angiogenesis in the tail, head and 
formation of the SIV complex. Left: DMSO treated embryos, Right: Birb796 treated 
embryos. A-B Tg(Fli:eGFP) embryos treated with Birb796 lack sprouting of ISV  at 
1,5dpf.  A Stereo images and B Confocal images 40X magnification C At 3,5dpf also 
brain, eye vasculature where underdeveloped 10X magnification and D the SIV was 




With 0.1 pmol P38α morpholino a significant pool of embryos can be distinguished 
displaying morphological defects where the ISV have not grown into DLAV 
compared to standard control morpholino injected embryos Fig1b. In addition, an 
enlargement of the intermediate cell mass (ICM) was clearly visible in P38α 
morpholino injected embryos. Scanning confocal microscopy revealed absence of 
the filopodia on the tip cells of growing ISV indicating defective endothelial cell 
migration in P38α morphants Fig1c. Endothelial cells of ISV appeared also more 
stretched in control embryos than in P38α morphants.  The P38 morpholino 
phenotype on sprouting ISV was confirmed by the pan P38 inhibitor BIRB796 Fig2. 
When applied between 4-7 somite stage the inhibitor blocked sprouting of ISV from 
the dorsal aorta Fig2a-b. BIRB796 was also applied at 2dpf resulting in 
undeveloped head/eye vasculature. After this treatment the subintestinal vein (SIV) 





Fig3. GFP+ cells are FACs sorted from embryos for transcriptome profiling to discover 
endothelial genes important for physiological angiogenesis. A Single unattached cells 
were sorted (P1, P2 and P3) of which approximately 3% was GFP+ (P4) and 97% GFP- 
(P5). B WT 24hpf dissociation time point; Tg(Fli;GFP) embryos were kept o/n at either 
28˚C or 31˚C. C Bar graph of Q-pcr results comparing fli and flt4 expression in RNA 
samples from sorted cells. Graphs are calculated from the mean of a biological duplicate. 
D number of transcripts identified and the number of overlapping transcripts. Threshold 
settings fold change >2 and p-value <10
-5





Transcriptional analysis of fli expressing cells isolated from Tg(Fli:GFP) 
To characterize the transcriptome of Fli expressing cells RNA from FACS sorted 
GFP+ cells was hybridized against GFP- RNA from Tg(Fli:GFP) on a 180k Agilent 
chip Fig3. Two stages of ISV development were analyzed at 24hpf. The first pool of 
embryos was kept overnight at 28˚C and at 24hpf the ISV were still growing and did 
not connect to form the DLAV. In contrast, the second pool was kept overnight at 
31˚C and at 24hpf the ISV were fully grown and DLAV was formed Fig3b. 
Expression analysis of Fli1 and Flt4 with Quantitative PCR, comparing GFP+ 
against GFP-, confirmed successful sorting of endothelial cells and RNA quality 
used for transcriptome analysis Fig3c. In the 28˚C grown embryos a total of 1181 
genes were expressed with a fold change above 2 (p<10-5) in GFP+ cells compared 
to GFP- cells. The transcriptome of the 31˚C grown embryos consist of 1536 genes 





Identification of P38α target genes involved in physiological angiogenesis 
To identify the P38α target genes involved in physiological angiogenesis P38α 
morphants with delayed growth of ISV were snap-freezed in liquid nitrogen for 
transcriptome analysis. Standard control morpholino injected embryos were taken 
as a control.  Under this unsaturated knock-down condition a total of 365 genes 
were identified as P38α dependant of which 173 upregulated and 192 
downregulated compared to standard control morpholino. Tyrosine kinase, non-
receptor, 2 (Tnk2) and runt-related transcription factor 1 (Runx1) were identified 
among the upregulated genes. The downregulated genes contained vascular 
Fig4. Transcriptome profiling of P38α morphants displaying vascular defect. A Number 
of identified genes in 0.1pmol P38α morpholino injected embryos with some selected genes of 
interest. results are from a biological triplicates. B Bar graph of Q-PCR expression analysis of 
Tagap, Vezf1 and Tnk2. Means are calculated from a biological triplicate. Expression levels 




endothelial zinc finger 1 (Vezf1) and myocyte enhancer factor 2A (Mef2A). Embryos 
in this experiment were kept overnight at 31˚C. The P38α transcriptome could 
therefore be compared with the 31˚C transcriptome of sorted Fli:GFP+. The overlap 
contained 2 genes lectin, galactoside-binding, soluble, 9 (galectin 9)-like 1 
(Lgal29l1) and T-Cell Activation GTPase-Activating Protein b (Tagapb) both 
downregulated. Results were validated with Q-PCR which was successful for all 
genes except Runx1 which is located at the telomere of chromosome 1 and specific 
primers could not be designed. Lgals9l1 and Mef2a displayed inconsistency 
between biological triplicates and Tnk2 showed a small fold change of 1,2. Tagap 
and Vezf1 were significantly downregulated in P38α morphants compared to 




The zebrafish contains all of the 14 MAPK identified so far in mammals including the 
four P38α isoforms. As the rodent and human cell culture experiments indicated 
previously, the angiogenesis process depends on P38α activation. In this study, we 
investigated the role of P38α in zebrafish embryonic angiogenesis. We observed 
that targeted knock-down of P38α, with gene specific morpholino in Tg(fli:EGFP) 
delayed the growth of intersegmental vessels significantly. Birb796, a chemical 
inhibiting all P38 isoforms, abolished the sprouting of ISV as well and was even 
more potent in inhibiting angiogenesis then the morpholino. The concentration of the 
morpholino was downscaled in order to prevent morphological abnormalities and 
therefore the downregulation of P38α mRNA was only partly effective. In addition, 
the possibility exists that all four P38 isoforms redundantly regulate angiogenesis in 
the zebrafish and therefore the phenotypes after Birb796 treatment were more 
severe. With transgenic zebrafish technology using a dominant negative mutant of 
P38α (and other isoforms) the specificity of the angiogenic phenotype can be further 
investigated. Also, by using promotors or control elements of endothelial specific 
marker expression such as fli, kdrl the question can be answered whether the 
defective growth of ISV is a result of P38α knockdown in the endothelial cells or due 
to knockdown in the surrounding tissue.  
 
When visualizing the ISV in more detail we found in P38α morphants the lack of 
filopodia sprouts that are normally present on the tip cells. Since P38α influences 
the activity of transcription factors we performed transcriptome analysis to 
characterize this defect at the level of gene expression. Sorting out GFP+ cells from 
Tg(fli:EGFP) for transcriptome analysis against GFP- provided a gene list of 
hematopoietic, pharyngeal and endothelial marker genes. This list obtained using 
180k Agilent chip is more complete then previously published list by group of 
Lawson and can be used as reference in the future research[24]. From comparison 
111 
 
of the P38α morpholino transcriptome with the GFP+/GFP- transcriptome we 
selected Tagapb as the endothelial expressed gene (zfin in situ data) 
downregulated by P38α morpholino.  
Interestingly we also found the transcription factor Runx1 to be 6 fold upregulated in 
P38α morphants. Runx1 is critical for definitive haematopoiesis and known to prime 
the hemangioblast (blood precursor) or hemogenic endothelium for differentiation 
into hematopoietic stem cells [25-27]. Hemogenic endothelium is a unique 
population of vascular cells that could give rise to blood cells. Perhaps the increase 
of Runx1 expression is related to the expansion of the intermediate cell mass we 
observed in P38α morphants. In zebrafish at 24hpf Runx1 expression is present in 
the dorsal aorta, posterior blood island (ICM) but also in the nervous system. 
Explaining why we did not find Runx1 mRNA enriched in GFP+ cells sorted from 
Tg(fli:EGFP). Mammalian Runx1 has previously been found functional in neuronal 
axon outgrowth and guidance a process which greatly resembles the navigation of 
blood vessels during angiogenesis[28]. Multiple axonal guidance cues, such as the 
semaphorins, are also involved in the blood vessel guidance[29]. Since P38α is 
expressed in the most tissues and also associated with neurite outgrowth it is likely 
to regulate downstream genes critical for angiogenesis even tough not exclusively 
expressed in endothelial cells[30]. Vezf1 is selected from the P38α morpholino 
transcription profile and are interesting for further functional studies in zebrafish. 
Vezf1 is a zinc finger transcription factor that regulates endothelial sprouting and 






Similarly as in mammals, zebrafish angiogenesis depends on P38 activity. However 
the endothelial cell autonomous specific function of P38α needs to be further 
addressed.  P38α morpholino reduces the expression of Tagapb of which 
expression is concentrated in endothelial cells. Furthermore, the expression of 
Runx1 is increased in P38α morphants. P38α signalling leads therefore to the 
suppression of this gene in endothelial, hematopeotic or hematopeitic endothelial 
cells. Since the molecular mechanisms of hemogenic endothelium differentiation is 
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General discussion  
 
The Mitogen activated protein kinase (MAPK)family is engaged in complex networks 
of signal transduction orchestrating cellular behaviours such as proliferation, 
differentiation, migration and apoptosis. MAPK signalling depends highly on the 
cellular environment as the cascades can respond to different extracellular cues. 
What adds also to signalling complexity is the presence of various MAPK family 
members and isoforms which can be functionally redundant in one cellular context 
while differing in another context where they can even antagonize each other. In 
addition, several factors such as the presence and abundance of activated 
receptors, presence of scaffold or adaptor proteins, or crosstalk with other 
pathways, collectively fine tune the duration and magnitude of MAPK signals to 
direct a precise cellular response. Giving this complexity, precise elucidation of the 
molecular mechanisms underlying MAPK associated cellular processes or 
pathologies remains challenging.  
 
The use of multiple experimental models is valuable to discover MAPK conserved 
functions among species. In this thesis the zebrafish model is used for further 
understanding the role of MAPK protein family in embryogenesis. Since most MAPK 
proteins are conserved within vertebrates the zebrafish is a suitable model to study 
functional redundancies and specialisations between different members during 
development. Firstly we have approached this study by applying probes to display 
specific tissue expression of different MAPK genes. Secondly, we have developed 
tools to up-regulate and down-regulate MAPK cascades by generating mutants with 
increased kinetic activity and by using morpholino knockdown, dominant negative 




Activated forms of the upstream ERK kinases RAF and RAS were used for the 
study of cell transformation and for discovery of anti-cancer drugs. Being part of the 
RAS-RAF-MEK1/2-ERK1/2 cascade, ERK2 is often hyperactivated in tumors 
harbouring oncogenic EGFR, RAF and RAS mutations1. However this cascade is a 
core module within a complex signalling network involving positive and negative 
signalling loops, isoform availability and crosstalk with other cascades. To 
understand isoform specific signalling differences between ERK1 and ERK2 in 
development and tumor formation we constructed intrinsically activated forms 
refractory to inhibition (chapter II). Since naturally occurring activating mutations in 
ERK have never been identified in cancer patients, developing artificial constitutively 
activated mutants was necessary. Giving its physiological functional importance and 
involvement in severe pathologies, ERK2 was an interesting subject for former 
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structural studies using crystallographic methods2;3. The activated (phosphorylated) 
structure and inactivated (unphosphorylated) ERK2 structure were solved and an 
overlap revealed the conformational changes, resulting from phosphorylation of the 
dual phosphorylation site, that facilitate kinase activity and make the protein more 
accessible for substrate binding. Phosphorylation of the dual phosphorylation site of 
ERK2 triggers a complex reorganization of hydrogen bounds between amino acids 
resulting i.a. in the positioning of the activesite.  Increasing ERK2 kinetic activity with 
a simple strategy was impossible and mutational screening for constitutive active 
mutants were carried out to identify mutations that mimic this effect. Brunner et al. 
was successful in developing  an active mutant of the Drosophila ERK2 ortholog 
Rolled by mutating the docking domain on ERK2 recognised by inhibiting 
phosphatases (D330N zebrafish)4. This mutation was called the sevenmaker 
mutation and the mutation site was conserved among various species. Furthermore, 
other gain-of function mutations were published from yeast genetic screens of Fus3. 
Emrick et al.2001 measured the in vitro kinetic activity of yeast ERK2 double and 
triple mutant combinations relative to ERK2 basal activity and we have selected the 
most potent combinations for generating similar constitutively active zebrafish ERK2 
mutants5.  
 
We inserted the same mutations in ERK1 and we found the triple mutant, including 
the sevenmaker mutation (D352N zebrafish), to increase ERK1 phophorylation in 
vitro. However, we could not measure any differences in the phosphorylation of 
P90RSK or CREB which are known ERK1/2 substrates. ERK1 and ERK2 are more 
than 80% identical, yet when targeted for gene disruption ERK2 deficiency appears 
to results in dramatic effects while ERK1 seems to be dispensable for cell 
physiology. Two hypotheses are proposed stating i) that differences in  expression 
levels between the low expressed ERK1 and the abundantly present ERK2 is the 
main and exclusive reason for the observed functional differences6 or ii) that ERK1 
signalling to the nucleus is less efficient than ERK2 and acts as a partial agonist in 
the ERK1/2 cascade7. A partial agonist binds the same upstream activators as the 
full agonist (ERK2), however, this is less efficient to transmit the signal further 
downstream of the cascade. The slow ERK1 activity becomes more significant in 
situations of prolonged cascade stimulation and high demand of activated ERK1/2. 
In support for this second hypothesis, ERK1 depletion in wild-type conditions is 
compensated by increased phosphorylation of ERK2 and has no effect on cell 
proliferation. However, proliferation of oncogenic H-RasQ61L transformed cells with 
hyperactivated ERK2 was inhibited by ERK1 overexpression. This suggests that 
ERK1, as a partial agonist of ERK2, protects cells from excessive proliferation. 
Differences in ERK1 and ERK2 downstream signaling can be explained by the 




The partial agonist model may also explain the relationship between two other 
MAPK protein studied in this thesis, the P38α and P38β isoforms, which are 75% 
homologous and share upstream and downstream kinases. P38α is essential for 
embryonic development while mice lacking P38β survive normally and do not show 
any obvious phenotype10;11. P38α plays a key role in various developmental 
processes (myoblast differentiation, neural differentiation, survival, cell migration, 
proliferation and cytokine production) while P38β function within the Mekk3/6-
P38α/β cascade seems to be insignificant12. Over activation of P38s is believed to 
be part of the cause for various inflammatory diseases, including inflammatory 
bowel diseases and rheumatoid arthritis, as well as for congestive heart failure and 
breast cancer13-15. It would be interesting and valuable to know if P38β acts as a 
partial agonist of P38α signalling during these processes especially in cytokine 
biogenesis. There are gain- of function mutations published for all P38 isoforms 
potentially useful to engineer the corresponding zebrafish proteins16;17. Transgenic 
zebrafish stably expressing such mutated P38 MAPKs will be valuable for future 




All P38 MAPK isoforms are maternally expressed and, except for P38δ, the level of 
expression, remains constant during embryonic development.  P38δ mRNA was 
detected for the first time at 16 cell stage. Interestingly, we found all P38 isoforms to 
be expressed in the brain of the zebrafish including the P38α and P38β isoforms of 
which expression was demonstrated previously in the adult mouse brain18. These 
results suggest that the P38 pathway may play an important role in the development 
and/or normal physiology of the brain. P38α/β is found to play a role in synaptic 
plasticity in the hippocampus19;20. The functions of the other isoforms in the brain 
are not known yet. The transcriptome data of the P38α morpholino knock-down 
embryos (Chapter IV) included a gene pool associated to the nervous system such 
as Neuropillin 2b, Fgf4, Elavl3, Actn3a, Stathmin, Ceruloplasmin, Lhx5, Ncam and 
Gbx-2 which were down-regulated and the upregulated Emx1, Crx, Camk4, Mxtx1, 
Bdnf protein, Her8a, Her11, Endothelin type A, Dishevelled 1b (dvl1b), Vega2, 
opcml, Isl1, Asl1b, reticulon 1, Jagged 1b, Fbln5 and zic3. This genes list includes 
possible direct target genes of P38α functioning in the nervous system development 
and neuronal physiology and when validated will give more insight into the role of 
P38α in this process. It would be interesting to compare with transcriptome data of 
other MAPK family members to reveal specificity.    
 
 In future research it would be interesting to perform quantitative PCR analysis to 
detect P38 isoform expression relative to each other. Once having developed 
reliable P38 isoform specific probes, primers and antibodies expression data can be 
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obtained in different in vivo contexts.  Expression analysis can be combined with 
functional studies involving treatment of zebrafish with stressors such inflammatory 
cytokines, bacteria, wounding, irradiation etc. to determine possible changes in 
expression. To analyze protein translation and activation isoform specific antibodies 
are necessary. These are currently available for the P38α isoform. Structural 
alignment of the P38 isoforms revealed a mutation prone domain which can be 
exploited to develop specific antibodies. The P38α and P38β isoforms share the 
highest sequence similarity and since phospho-P38α specific antibodies have been 
developed it should also be possible to obtain such antibodies for the β, δ and γ 




The function of ERK2 in development was investigated in mouse, drosophila, sea 
urchin, xenopus and zebrafish models leading to the key finding of a conserved 
ERK2 cascade downstream of FGF regulating trophoblast differentiation and 
gastrulation cell movements in the first embryonic stages21. Later on the pathway is 
involved in formation of branchial arches, migrating neural crest cells, the 
midbrain/hindbrain boundary and forebrain22. The role of P38α in developmental 
processes has been predominantly studied in the relation to skeletal muscle 
development23. However, in zebrafish we have previously demonstrated the 
expression of all P38 isoforms, including P38α, in specific regions of the developing 
brain suggesting a role of this MAPK subfamily in development of the central 
nervous system as well. As already mentioned several genes important for 
neurogenesis were affected by P38α morpholino knock-down (Chapter IV). Some of 
these genes, Zic3, Fgf4, Elavl3, Her11, Stmn, Lhx5, Ncam, Vega2, Asl1b are also 
present in the ERK2 morpholino transcriptome which also includes Flh, Zic2, Hxb8a, 
Tcf12, Rx3, Gsc, Barhl2, Efna-L1, Cp, Irx1b, Rtn3, Dlc, Cxcr4, Dlx1a, irx7, Otx1a, 
Acha from the ERK2 specific pool. Neural crest cells arise from the edges of the 
nascent central nervous system, a domain called the neural plate border (NPB). 
ERK2 and P38α might be both involved in this process by stringing along in 
regulation of zic3 expression as Zic2 and Zic3 proteins function in specification of 
the NPB. Finally, both the P38 and ERK2 MAPK are expressed at the margin of the 
blastoderm prior and during epiboly and knock-down results in arrested embryos 
failing to initiate this process. We found a number of epiboly functional genes 
concurrent and specifically affected by P38α and ERK2 morpholino knockdown. 
Altogether our transcriptome data indicates that ERK2 function in development is 
partly redundant with the P38α MAPK which is an interesting finding for further 
validation using other genetic tools. It remains a question whether the specific pools 
of target genes deduced from P38α/ERK2 knock down comparisons contain genes 




Unlike other vertebrates, the zebrafish contains two copies of the P38α gene and 
we have found that morpholino knock-down of P38αA or P38αB results in epiboly 
arrested phenotypes (data not shown). As expected, reduced presence of P38α 
protein but not Erk2 was detected in P38αA morphants with western blotting using a 
gene duplicate aspecific antibody. However, a down-regulation of P38α was 
detected in Erk2 morphants and since the anti-P38α antibody does not distinguish 
between the two genes it was not clear from the biochemical analysis data which 
one is down-regulated in Erk2 morphants. We have performed transcriptome 
analysis of P38αB morphants (data not shown) and the transcriptome largely 
overlaps with Erk2 transcriptome data. Considering that we do identify a large pool 
of P38αA specific regulated genes it is likely that P38αB is down-regulated in Erk2 
morphants and not P38αA. Data presented in this report and further discussion is 




Using genetic and chemical tools we demonstrated that P38α is functional in 
zebrafish angiogenesis. With unsaturated P38 morpholino knockdown conditions we 
found 4 genes (Annexin1, Tnk2, Runx1, Vezf1) to be effected. Three of them are 
previously implicated in angiogenesis and one (Tagap) with expression enriched in 
the vasculature having an undescribed function in this process. The concentration of 
the morpholino was down scaled to circumvent severe morphological defects with 
the disadvantage that many P38α regulated genes were most likely not picked up 
by microarray transcriptomics. However, this limited number of effected genes is 
interesting for further validation experiments to identify P38α target genes and 
understand the role of this MAPK family in angiogenesis. P38α was proposed to 
have a tumor suppression function by activating several cell cycle checkpoint 
proteins including P5324;25. The role of P38α in tumor progression has two sides 
since P38α promotes tumor angiogenesis and metastasis. A detailed understanding 
of cell type specific P38α signalling will be valuable for designing new drug that 
intervene in steps in cancer development in which the P38 proteins play a role.   
 
We have isolated GFP+ cells of pharmacological treated Tg(fli:EGFP) embryos by 
FACS for transcriptional profiling. This method would be valuable to determine cell 
type specific effects after pharmacological treatment. Zebrafish xeno-transplants are 
being used for high-throughput chemical screens for anti-cancer drugs. With the 
growing repertoire of zebrafish transgenic lines, that mark specific cell types or 
stages of immature differentiating cells based on identified marker genes, the 
treatment effects can be analyzed in detail. We treated Tg(fli:EGFP) embryos with 
Birb796, an P38 inhibitor severely impeding angiogenesis, in the trunk and head. 
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cDNA samples of sorted GFP+ cells were hybridised on a 180k Agilent array for 
transcriptome analysis.  We also hybridised samples from GFP+ cells against GFP- 
cells and obtained a pool of genes of which expression is enriched in pharyngeal 
arch, hematopoietic or endothelial cells. These comparisons indentified a high 
number of genes with high fold changes compared to control samples representing 
tissues from the entire organism which could be validated with Q-pcr. Q-pcr analysis 
of Fli, Flt4 and Tbx6 indicates that after FACS sorting different ratios of endothelial 
and blood cell populations were obtained. The ratio differences could have been the 
result of a sampling error that presumably overshadows the treatment effect but did 
not interfere with the detection of transcripts with significantly high fold changes. 
Optimalization of sampling conditions to obtain samples with constant ratios of cell 




The capacity to predict treatment outcomes is highly depending on understanding 
molecular mechanisms of disease associated cellular processes. Tools to 
manipulate activity, or study expression and activity of one particular protein allow 
researchers to draw a precise map of the molecular events.  Giving the existence of 
multiple MAPK variants and the divers cellular processes that are regulated, 
extensive input and different approaches of research is necessary to tackle the yet 
unknown facts regarding this protein family. How is MAPK signalling translated into 
different cellular behaviours such as proliferation, differentiation and migration? 
What are the mechanisms that control MAPK signalling localization, duration and 
amplitude in such a way to favour and sustain a particular cellular state. Finally how 
does deregulation of these mechanisms lead to disease. 
 
This thesis was produced within the scope of the research interest of the Molecular 
Cell Biology department of Leiden University in the Netherlands which has a 
background investigating the MAPK pathway in development and cancer using the 
zebrafish. With the current study we provided new tools to mimic uncontrolled ERK2 
activity found in tumours and to investigate the exact role of this MAPK family 
member in cell transformation. We have completed cloning and expression analysis 
of the P38 MAPK subfamily in zebrafish and provided a basis for research on 
isoform specific functions. Both P38α and ERK2 are essential for zebrafish epiboly 
and by comparing the transcriptome profiles of knock-down embryos we identified 
epiboly associated genes of which are commonly or specifically regulated by the 
two MAPK. Finally we have demonstrated that  P38α is also functional in migration 
of endothelial cells during angiogenesis and we identified candidate target genes 
that are possible involved in this process. Using different approaches we aimed to 
123 
 
make use of the many advantages of the zebrafish and combine the fields of 
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De functies van P38 en ERK kinasen in de vroege ontwikkeling van de 
zebrafish 
 
Mitogen activated protein kinases (MAPK) vormen een eiwitfamilie, die een rol 
speelt in de signaaltransductie van de cel. Het zijn kinase enzymen die de 
overdracht van een fosfaat groep van ATP naar substraten katalyseren en het 
substraat wordt daarbij geactiveerd. De MAPK eiwitfamilie komt voor in alle 
eukaryoten en er zijn maar liefst 14 isovormen geïdentificeerd in gewervelden. 
MAPK functioneren in cascades van eiwitten die signalen overdragen vanuit het 
celmembraan naar andere compartimenten van de cel om een cellulaire respons te 
genereren t.g.v. veranderingen in de micro-omgeving. De nucleus is een van de 
cellulaire organen waar MAPK zich naartoe verplaatsen na activatie. MAPK 
beïnvloeden in de nucleus de activiteit van transcriptie factoren en daarmee de 
expressie van genen. Er zijn drie MAPK subgroepen te onderscheiden namelijk de 
extracellular signal regulated kinases (Erk1,2,3,4,5,6,7), de c-Jun amino-terminal 
kinases (Jnk1/2/3) en de P38 MAPK (α,β,γ, and Δ).  
 
Er is tot heden ongeveer dertig jaar onderzoek verricht om de functies van MAPK 
eiwitten in diverse cellen en onder verschillende condities te achterhalen en er is 
aanzienlijk veel informatie verworven. Extracellulaire stimulansen, 
membraaneiwitten (receptoren), substraten en overige eiwit interacties die de 
cascade beïnvloeden zijn geïdentificeerd en goed in kaart gebracht voor enkele 
isovormen. Het meeste informatie is verworven met betrekking tot Erk2 en P38α 
MAPK. Deze twee MAPK zijn met name interessant omdat ze essentieel zijn 
gebleken voor verschillende cellulaire functies. Afwijkende Erk2 en P38α activiteit 
wordt geassocieerd met verschillende aandoeningen. Erk2 reguleert, als gevolg van 
stimulering met groeifactoren, de celdeling en in verschillende vormen van kanker 
(bijvoorbeeld melanoma) is de Erk2 cascade hyperactief aanwezig. De P38α MAPK 
cascade wordt voornamelijk door stress signalen gestimuleerd zoals endotoxinen, 
DNA beschadigende radiatie, osmotische stress, en functioneert o.a in de aanmaak 
van cytokinen. Cytokinen zijn eiwitten die een belangrijke functie vervullen in het 
immuunsysteem maar ook ontstekingen kunnen veroorzaken. P38α is betrokken bij 
verschillende ontsteking gerelateerde aandoeningen zoals rheumatoid arthiritis. 
Tevens vervullen Erk2 en P38α een essentiële rol in de vroege ontwikkeling van 
zoogdieren. Muis embryos waarvan het Erk2 of P38α ontbreekt overlijden in een 
zeer vroeg stadium gedurende de eerste 11 dagen na fertilisatie. Alhoewel er veel 
bekend is over beide eiwitten is het nog onduidelijk hoe verschillende MAPK 
isovormen gemeenschappelijk betrokken zijn bij cellulair processen die vaak door 
een combinatie van meerdere signaaltransductie cascades worden gereguleerd. 
Door verder onderzoek te doen naar specifieke en overeenkomstige functies van 
MAPK isovormen ontstaat er meer duidelijkheid over de rol van eiwitfamilies in de 
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ontwikkeling en handhaving van (specifieke) karaktereigenschappen van cellen. Om 
MAPK gerelateerde aandoeningen beter te begrijpen en behandelingen te 
ontwikkelingen, is het tevens van belang om de functies van afzonderlijke MAPK te 
onderzoeken.    
 
Wij zijn daarom geïnteresseerd in de specifieke rol van MAPK in embryologische 
processen om uiteindelijk meer inzicht te krijgen in de pathogenese van tumoren. 
Tumor en embryonale cellen hebben de capaciteit om continue te delen en de 
cellulaire mechanismen die bedoeld zijn om de celdeling te beperken ontbreken. 
Daarbij zijn het ongespecialiseerde cellen die niet volledig gedifferentieerd zijn tot 
een celtype met een specifieke functionaliteit zoals erytrocyt, endotheelcel of een 
hepatocyt. Wanneer muizen getransplanteerd worden met embryonale stamcellen 
ontstaan er teratomas, tumoren bestaande uit verschillende soorten weefsels. Ook 
op moleculair niveau blijken bepaalde eiwitten met een essentiële functie in 
embryologie betrokken te zijn bij de metastasering van tumoren.  De MAPK 
eiwitfamilie is bijvoorbeeld betrokken bij zowel embryologische processen als 
kanker en door deze eiwitfamilie als uitgangspunt te nemen kunnen we een relatie 
leggen tussen deze twee processen op moleculair niveau. We gebruiken de 
zebravis vanwege de praktische voordelen die het een geschikt model organisme 
maken voor embryologisch en kanker onderzoek. Een zebravis paar kan 200-300 
bevruchte eitjes leggen na een periode van 10 uur donker wat de mogelijkheid biedt 
om een significant aantal embryo's van een gewenste embryonale stadium te 
verzamelen voor een experiment. De ontwikkeling van zebravis embryo's geschied 
extern van de zebravis waardoor de morfogenese microscopisch gevolgd kan 
worden. Binnen een dag zijn de meeste organen ontwikkeld en is het bevruchte 
eitje uitgegroeid tot een herkenbaar visje. Zebravis embryo's zijn transparant en 
kunnen geïnjecteerd worden met stoffen of getransplanteerd worden met (tumor) 
cellen. Dit proefschrift is een vervolg van eerder verricht onderzoek van Dr. Krens 
(Proefschrift: The mitogen activated protein kinases in zebrafish development) en 
omvat de resultaten van vier verschillende projecten naar de rol van MAPK eiwitten 
in de ontwikkeling van zebravissen.  
 
Om de hyperactiviteit van Erk2 in tumor cellen na te bootsen hebben we, met het 
project beschreven in hoofdstuk II, mutanten ontwikkeld met een verhoogde 
kinetische activiteit. Dit is gebeurd door specifieke puntmutaties te introduceren in 
Erk2, bedoeld om de eiwitstructuur zodanig te veranderen dat autofosforylering 
mogelijk wordt en inactiveren wordt belemmerd. Constructen met genen coderend 
voor gemuteerde en wild type Erk2 zijn getransfecteerd in zebravis fibroblast cellen 
en ik heb aangetoond dat de mutanten een verhoogde capaciteit hebben om reeds 
bekende substraten te fosforyleren. Daarnaast is de verhoogde kinetische activiteit 
gevalideerd in zebravis embryo's. Er is mRNA gesynthetiseerd, gebruik makend van 
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de Erk2 constructen, en geïnjecteerd in embryo's van transgene zebravissen die het 
groen fluorescerend eiwit (GFP) produceren onder controle van de promotor van 
het Dusp6 gen. De Dusp6 promotor wordt beïnvloed door signalen van de ERK2 
cascade en een verandering in de activiteit van deze cascade is kwantitatief vast te 
leggen in deze transgene zebravissen door het GFP signaal te detecteren.  De 
mutant met drie geïntroduceerde punt mutaties heeft een sterke verhoging van het 
GFP signaal veroorzaakt en is verder gebruikt om de effecten van verhoogde Erk2 
activiteit te bepalen m.b.v. peptide microarrays. Lysaten van embryo's geïnjecteerd 
met RNA coderend voor de drievoudige mutant veroorzaken een verhoogde 
fosforylering van het CDK1 eiwit dat betrokken is bij de celdeling. Hierdoor 
concluderen wij dat de drievoudige mutant gebruikt kan worden om Erk2 
hyperactivatie te creëren in specifieke cellijnen van de zebravis om mogelijke 
gevolgen voor celdeling en cel transformatie te bestuderen. 
 
In hoofdstuk III hebben we het expressiepatroon van P38β en P38δ gedurende de 
ontwikkeling van de zebravis bestudeerd. P38β RNA is detecteerbaar vanaf de 
zygote, wordt maternaal overgedragen en blijft detecteerbaar gedurende een reeks 
aan stadia, tussen zygoot tot vijf dagen post fertilisatie, van ontwikkeling. P38β 
expressie is gelokaliseerd in het brein, hart en de lens.  P38δ wordt niet maternaal 
overgedragen en het expressiepatroon is meer variabel tijdens de vroege zebravis 
ontwikkeling. P38δ komt tot expressie in het chondrocranium, borstvinnen, brein, 
voorlopers van de kieuwen, darm, en mogelijk de groeiende venen.   
 
P38α en Erk2 zijn twee MAPK die essentieel zijn voor cel migratie processen die 
belangrijk zijn voor de gastrulatie een proces waarbij embryonale cellen 
differentiëren tot drie kiemlagen het mesoderm, ectoderm en endoderm. In 
hoofdstuk IV  is aangetoond dat het injecteren van stoffen die de translatie van Erk2 
of P38α RNA blokkeren resulteert in een volledige remming van de celmigratie van 
embryonale cellen, en daardoor ook de gastrulatie. Omdat beide MAPK betrokken 
zijn bij dit proces hebben we verder onderzocht hoe de stoffen de embryos zodanig 
beïnvloeden dat de ontwikkeling wordt geremd. Met transcriptome microarrays 
hebben we genen geidentificeerd die een rol spelen in de embryonale celmigratie.  
De genen worden ofwel door Erk2 en P38α gemeenschappelijk gereguleerd danwel 
afzonderlijk. Tevens was de expressie van een aanzienlijk aantal genen coderend 
voor ribosomale eiwitten verlaagd in embryos geinjecteerd met gemanipuleerd P38α 
expressie en niet in embryos met afwijkend Erk2 eiwit gehalte. Dit duidt op een 
specifieke interactie functie tussen de twee MAPK in signaaltransductie gedurende 
stress wat al ontwikkeld is in embryonale stadia.  
 
In hoofdstuk V is aangetoond dat P38α tevens een belangrijke rol speelt in de 
migratie van endotheel cellen, die de binnenkant van bloedvaten uitlijnen. De groei 
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van nieuwe bloedvaten kan bestudeerd worden m.b.v transgene zebravissen 
bevattende GFP gemarkeerde endotheel cellen. Gedoseerde toediening van P38α 
blokerende stoffen aan zebravissen veroorzaken afwijkingen in de vorming van het 
bloedvatenstelsel tijdens de ontwikkeling door obstructie van angiogenese 
(bloedvaten vertakkingen). P38α is ook betrokken bij de angiogenese van 
zoogdieren (muizen) tijdens ontwikkeling. Wij hebben aangetoond dat de functie 
van P38α in angiogenese evolutionair geconserveerd is in zebravissen. De 
specifieke rol van P38α in deze context kan daarom verder bestudeerd worden 
m.b.v het zebravis model. Tevens hebben we op transcriptie niveau gekeken naar 
de effecten van P38α manipulatie in endotheel cellen en we hebben daarbij een 
aantal gen kandidaten geidentificeerd die een rol spelen in angiogenese en mogelijk 
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